{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "77e451fe-6a21-4316-ba57-3ddd75606d3d",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import sys\n",
    "\n",
    "sys.path.insert(1, \"..\")\n",
    "\n",
    "import utils as u\n",
    "import eda as e\n",
    "import stats as s\n",
    "\n",
    "pd.set_option(\"mode.chained_assignment\", None)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "32eb1340-486e-4e3a-ae9e-4865fb9e7d60",
   "metadata": {},
   "source": [
    "# Project HER2"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bfbe0ea5-1a45-4c43-969f-4a1c0d39a839",
   "metadata": {},
   "source": [
    "## Created by Stilyan Chanev"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "52e20af9-19fb-4c16-b4a8-79a82c40d9e7",
   "metadata": {},
   "source": [
    "## Project Idea: Integrate breast cancer molecular subtype data with drug response profiles"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0398e000-a696-4ba9-ace2-24fed1700aec",
   "metadata": {},
   "source": [
    "### Hypothesis: HER2-positive tumors have higher HER2 pathway activity, and HER2-targeted (or closely related) drugs reduce cancer cell viability more than non-targeted agents."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bd9e65f2-7733-4a00-ba8b-d514cfaee2f2",
   "metadata": {},
   "source": [
    "### Objective: Compare HER2 pathway activation between HER2-positive and -negative tumors and evaluate whether that activation aligns with stronger drug efficacy in corresponding targeted treatments."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d3c33c87-0cb0-4e4f-bcf7-9d653e805901",
   "metadata": {},
   "source": [
    "## Abstract"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a929a3d0-25e2-414f-a48b-96e7bf8919f5",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> HER2-positive breast cancer is driven by ERBB2 signaling and is clinically actionable; we analyze two curated datasets to test whether (i) higher HER2 pathway activity relates to survival, (ii) HER2-targeted drugs reduce in-vitro viability more than non-targeted agents, and (iii) clinical HER2 status aligns with pathway activation. Using a median split of pp_HER2, vital status differed between High and Low groups ($\\chi$^2 p=0.040; Fisher p=0.031), with lower death odds in the High group (OR=0.55; deaths 9.1% vs 15.4%). Pooled across doses, HER2-targeted inhibitors exhibit markedly lower viability distributions than comparators, consistent with greater potency. Finally, HER2-positive tumors show higher pathway activity than HER2-negative tumors, with median pp_HER2 1.881 vs −0.154. Together, these nonparametric results - robust to skew and ties - support biological coherence across label, signaling, and function: HER2 positivity tracks elevated phospho-HER2 signaling, and HER2-directed agents more strongly suppress cell viability, mirroring clinical experience with HER2-targeted therapy. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "578b6804-dfb1-4a95-a13e-c9dedfeef7e7",
   "metadata": {},
   "source": [
    "## 1. Introduction, Ideas and Background of the Project"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9e8e627a-6afb-4f2c-b288-a2840f3257a4",
   "metadata": {},
   "source": [
    "### 1.1. Main Ideas and Aims"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0d3c83e7-ff99-4676-84d2-ba055e2b0626",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> ProjectHER2 is a natural evolution of my earlier work in ProjectDNA, where I explored mutation models (Jukes-Cantor and Markov chains) to understand how biological sequences change and propagate information. In that project the focus was on modeling and quantifying uncertainty in genetic data; here, I take the next step downstream and ask how molecular identity - specifically a clinically used label, HER2-positive breast cancer - is reflected in real biological signal and whether that signal predicts functional response to therapy. In other words, if the genome and proteome encode a subtype, does the treatment landscape behave as theory and biology would suggest? </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b8882469-ee68-451f-9ecd-285093c4d269",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> The core idea is to connect two independent data worlds: patient-derived molecular profiles (showing pathway activation and subtype labels) and in vitro drug sensitivity measurements. I test whether the HER2-positive phenotype corresponds to elevated HER2 pathway activity and whether drugs targeting that axis (or close biological proxies) result in stronger reductions in cancer cell viability. This project is about alignment - between label, underlying biology, and therapeutic effect - and demonstrates the data science pipeline from molecular signal to actionable insight, explaining the precision-medicine philosophy: use what the tumor \"says\" to choose what should be done. Cells won't stop fascinating me! ;) </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3238ebc5-924b-4c35-ab45-b7f8ad2a6a0a",
   "metadata": {},
   "source": [
    "![Human cell](../images/HumanCell.jpg)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5a434fbe-d75e-47f4-8b7e-1c909495e624",
   "metadata": {},
   "source": [
    "### 1.2. Biological Background"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d7524056-beee-4477-8950-fd664220a5e9",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> This project builds upon the biological foundations established in ProjectDNA, where core concepts such as cells, DNA, genes, the genome, and the nature of mutations were introduced in detail. For the purposes of ProjectHER2, we focus on how these molecular principles connect to breast cancer biology and targeted therapy. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "706017da-d9f8-4ab1-90cc-c492993f71e7",
   "metadata": {},
   "source": [
    "#### 1.2.1. HER2"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a47642b2-3bf6-4dae-b735-055f81aa9746",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> HER2 (human epidermal growth factor receptor 2) is a protein that plays a key role in regulating cell growth and division. In some breast cancers, the HER2 gene is amplified or overexpressed, leading to abnormally high levels of HER2 protein on the tumor cell surface. This \"HER2-positive\" status drives more aggressive tumor growth but also creates a therapeutic opportunity - drugs targeting the HER2 pathway can inhibit this signaling and reduce tumor viability. The biological insight that HER2 can drive cancer led directly to targeted therapies and dramatically better outcomes for HER2-positive patients. Clinically, this went from concept to survival gains in randomized trials. Adding tucatinib (a selective HER2 TKI) to trastuzumab/capecitabine improved progression-free and overall survival in HER2CLIMB; lapatinib plus capecitabine improved outcomes versus capecitabine alone in trastuzumab-pretreated disease - clear proof that shutting down HER2 signaling helps patients. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fb406c14-043f-41e9-ac50-cc4eff83d02e",
   "metadata": {},
   "source": [
    "![HER2](../images/HER2.jpg)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cfebea47-47de-46de-93e7-955ac5aa67b2",
   "metadata": {},
   "source": [
    "#### 1.2.2. ER and PR"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b5854efa-170a-405f-aa66-acf825b1a25b",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Two additional hormone receptors - estrogen receptor (ER - proteins found in cells that act as receptors for the hormone estrogen) and progesterone receptor (PR - proteins that bind to the hormone progesterone, triggering changes within cells) - are often assessed in breast cancer. Together, HER2, ER, and PR status define key molecular subtypes that influence prognosis and treatment choices. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2fb97a15-c404-41ec-88c9-e67fa55d8436",
   "metadata": {},
   "source": [
    "![ER](../images/ER.jpg)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7326f86d-6969-49c3-8038-793d9eb55842",
   "metadata": {},
   "source": [
    "![PR](../images/PR.jpg)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "273710d5-3d82-40cc-9213-0fd86c226d1d",
   "metadata": {},
   "source": [
    "#### 1.2.3. pp_HER2"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2a33755e-6d87-4790-84f5-8137623a3669",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> HER2 pathway activity can be measured at the protein level, including its phosphorylated form (pp_HER2), which reflects receptor activation. In ProjectHER2, pp_HER2 serves as the primary molecular readout for pathway activation, and its relationship to HER2 status, survival outcomes, and drug response is central to our analysis. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3e9b29e0-f8d8-4f26-a8b6-ae2dfead2142",
   "metadata": {},
   "source": [
    "![Phosphorylation](../images/Phosphorylation.jpg)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "861da77e-6c0d-4e5e-9907-d101bb3bf8b6",
   "metadata": {},
   "source": [
    "#### 1.2.4. Breast Cancer"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a1f65a5b-c21e-4fcf-a47a-a4c910889377",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Breast cancer begins when epithelial cells in the breast acquire alterations that allow uncontrolled growth and invasion. In practice, tumors are stratified by receptor biology - estrogen receptor (ER), progesterone receptor (PR), and HER2 - because these markers drive behavior and guide therapy. Patient-facing and clinical sources summarize the spectrum of symptoms, risk factors, staging, and multimodality care across surgery, radiation, endocrine therapy, chemotherapy, and targeted agents, framing why subtype matters for prognosis and treatment choice. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "03340215-7803-46f5-baee-92735459285f",
   "metadata": {},
   "source": [
    "![Breast Cancer](../images/BreastCancer.jpg)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d50a22ab-1302-49f5-9898-f6e9ec14ff65",
   "metadata": {},
   "source": [
    "#### 1.2.5. HER2 Pathway Activity"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ff07b32a-f5dd-4d51-b586-5dbb13b7243d",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Signal transduction through HER2 is phosphorylation-driven. A well-studied activation site is Tyr1248 (Y1248) on the HER2 cytoplasmic tail; phosphorylation at Y1248 (pY1248) tracks receptor activation and propagates downstream signals. Prior proteomic studies show elevated pHER2(Y1248) in HER2-driven contexts and link phospho-HER2 measurements to disease biology and outcome, reinforcing the idea that phospho-status captures activity, not just expression. In our data, pp_HER2 (and when present a pY1248-specific readout) serve as pathway-activity proxies. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e62b113f-b898-498d-af37-67954c535e5c",
   "metadata": {},
   "source": [
    "![HER2 Pathway Activity](../images/Pathway.jpg)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "17510f9b-7119-49af-847c-b654b713d3b0",
   "metadata": {},
   "source": [
    "#### 1.2.6. Viability"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "83c827d4-ebb8-4bbc-a09b-c4c7a8852ad2",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> To quantify drug effects in cell culture, high-throughput viability assays measure metabolically active/ATP-rich cells after treatment. A widely used method, CellTiter-Glo, reads cellular ATP via a luciferase reaction - more luminescence means more viable cells. Readouts are normalized to untreated controls to produce a fraction (0-1 or 0-100%) of surviving cells. Lower viability implies stronger growth inhibition, enabling dose–response curves and potency metrics like $IC_{50}$ (the concentration that reduces response to 50%). We leverage both pooled viability distributions and a simple \"fraction < 50% viability\" descriptor to summarize potency across doses, aligning with pharmacology guidance for concentration-response analysis. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "799c1ae2-b533-4538-add7-79200808e5c6",
   "metadata": {},
   "source": [
    "## 2. Data Description"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e779bbb3-bf3d-416d-8221-60380b460f00",
   "metadata": {},
   "source": [
    "### 2.1. Datasets Overview"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4804cdc7-0fa7-4c4a-808d-8946d1452f53",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> This project uses two independent CSV datasets that are connected via biological meaning. **Mutations / Proteomic Profile Data (`mutations.csv`)** shows patient-derived breast cancer samples with clinical subtype labels (like HER2 status, ER/PR status, histological type, survival) and quantitative pathway activity measurements. This dataset comes from The Cancer Genome Atlas (TCGA) breast cancer (BRCA) cohort, repackaged on Kaggle. Key features for this project are `HER2.Final.Status` and HER2 pathway activation proxies like `pp_HER2` and `pp_HER2.pY1248`. **Drug Sensitivity Data (`drug-sensitivity.csv`)** displays in vitro viability measurements of cancer cell lines after treatment with various drugs. This dataset comes from the Genomics of Drug Sensitivity in Cancer (GDSC) project, specifically the Sanger GDSC1 & GDSC2 screens, accessed via DepMap. Important columns are `DRUG_NAME`, `dose`, and `viability` (survival fraction), which allow comparison of targeted versus non-targeted drug effects. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "01cbfd02-4144-4567-84b3-7cf1fb766cd4",
   "metadata": {},
   "source": [
    "### 2.2. Loading and Initial Inspection"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8181f4c6-f172-4cb4-acac-88271cc013fa",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Now I present the data loading step in code.<br>\n",
    "The function <code>load_data()</code> takes: </p>\n",
    "<ul>\n",
    "  <li><b>data_dir</b> – path to the folder containing <code>mutations.csv</code> and <code>drug-sensitivity.csv</code>.</li>\n",
    "</ul>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "45bb664c-d79c-49d8-b9d0-bdda1bc69a53",
   "metadata": {},
   "outputs": [],
   "source": [
    "mutations_data, drug_sensitivity_data = u.load_data(\"../data\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3871df42-3465-4fee-924e-2612acf03305",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Let's begin with the size of the data we have here. </p>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "be479cf1-2555-48b7-bb22-381f9796dcc4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Mutations data shape: (705, 1941)\n",
      "Drug sensitivity data shape: (4049857, 8)\n"
     ]
    }
   ],
   "source": [
    "print(\"Mutations data shape:\", mutations_data.shape)\n",
    "print(\"Drug sensitivity data shape:\", drug_sensitivity_data.shape)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "5096a5e8-706e-4b34-977a-cd1a429214a3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>rs_CLEC3A</th>\n",
       "      <th>rs_CPB1</th>\n",
       "      <th>rs_SCGB2A2</th>\n",
       "      <th>rs_SCGB1D2</th>\n",
       "      <th>rs_TFF1</th>\n",
       "      <th>rs_MUCL1</th>\n",
       "      <th>rs_GSTM1</th>\n",
       "      <th>rs_PIP</th>\n",
       "      <th>rs_ADIPOQ</th>\n",
       "      <th>rs_ADH1B</th>\n",
       "      <th>...</th>\n",
       "      <th>pp_p62.LCK.ligand</th>\n",
       "      <th>pp_p70S6K</th>\n",
       "      <th>pp_p70S6K.pT389</th>\n",
       "      <th>pp_p90RSK</th>\n",
       "      <th>pp_p90RSK.pT359.S363</th>\n",
       "      <th>vital.status</th>\n",
       "      <th>PR.Status</th>\n",
       "      <th>ER.Status</th>\n",
       "      <th>HER2.Final.Status</th>\n",
       "      <th>histological.type</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.892818</td>\n",
       "      <td>6.580103</td>\n",
       "      <td>14.123672</td>\n",
       "      <td>10.606501</td>\n",
       "      <td>13.189237</td>\n",
       "      <td>6.649466</td>\n",
       "      <td>10.520335</td>\n",
       "      <td>10.338490</td>\n",
       "      <td>10.248379</td>\n",
       "      <td>10.229970</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.691766</td>\n",
       "      <td>-0.337863</td>\n",
       "      <td>-0.178503</td>\n",
       "      <td>0.011638</td>\n",
       "      <td>-0.207257</td>\n",
       "      <td>0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Negative</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>3.691311</td>\n",
       "      <td>17.116090</td>\n",
       "      <td>15.517231</td>\n",
       "      <td>9.867616</td>\n",
       "      <td>9.691667</td>\n",
       "      <td>8.179522</td>\n",
       "      <td>7.911723</td>\n",
       "      <td>1.289598</td>\n",
       "      <td>1.818891</td>\n",
       "      <td>...</td>\n",
       "      <td>0.279067</td>\n",
       "      <td>0.292925</td>\n",
       "      <td>-0.155242</td>\n",
       "      <td>-0.089365</td>\n",
       "      <td>0.267530</td>\n",
       "      <td>0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3.748150</td>\n",
       "      <td>4.375255</td>\n",
       "      <td>9.658123</td>\n",
       "      <td>5.326983</td>\n",
       "      <td>12.109539</td>\n",
       "      <td>11.644307</td>\n",
       "      <td>10.517330</td>\n",
       "      <td>5.114925</td>\n",
       "      <td>11.975349</td>\n",
       "      <td>11.911437</td>\n",
       "      <td>...</td>\n",
       "      <td>0.219910</td>\n",
       "      <td>0.308110</td>\n",
       "      <td>-0.190794</td>\n",
       "      <td>-0.222150</td>\n",
       "      <td>-0.198518</td>\n",
       "      <td>0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Negative</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>18.235519</td>\n",
       "      <td>18.535480</td>\n",
       "      <td>14.533584</td>\n",
       "      <td>14.078992</td>\n",
       "      <td>8.913760</td>\n",
       "      <td>10.557465</td>\n",
       "      <td>13.304434</td>\n",
       "      <td>8.205059</td>\n",
       "      <td>9.211476</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.266554</td>\n",
       "      <td>-0.079871</td>\n",
       "      <td>-0.463237</td>\n",
       "      <td>0.522998</td>\n",
       "      <td>-0.046902</td>\n",
       "      <td>0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Negative</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>4.583724</td>\n",
       "      <td>15.711865</td>\n",
       "      <td>12.804521</td>\n",
       "      <td>8.881669</td>\n",
       "      <td>8.430028</td>\n",
       "      <td>12.964607</td>\n",
       "      <td>6.806517</td>\n",
       "      <td>4.294341</td>\n",
       "      <td>5.385714</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.441542</td>\n",
       "      <td>-0.152317</td>\n",
       "      <td>0.511386</td>\n",
       "      <td>-0.096482</td>\n",
       "      <td>0.037473</td>\n",
       "      <td>0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Negative</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 1941 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   rs_CLEC3A    rs_CPB1  rs_SCGB2A2  rs_SCGB1D2    rs_TFF1   rs_MUCL1  \\\n",
       "0   0.892818   6.580103   14.123672   10.606501  13.189237   6.649466   \n",
       "1   0.000000   3.691311   17.116090   15.517231   9.867616   9.691667   \n",
       "2   3.748150   4.375255    9.658123    5.326983  12.109539  11.644307   \n",
       "3   0.000000  18.235519   18.535480   14.533584  14.078992   8.913760   \n",
       "4   0.000000   4.583724   15.711865   12.804521   8.881669   8.430028   \n",
       "\n",
       "    rs_GSTM1     rs_PIP  rs_ADIPOQ   rs_ADH1B  ...  pp_p62.LCK.ligand  \\\n",
       "0  10.520335  10.338490  10.248379  10.229970  ...          -0.691766   \n",
       "1   8.179522   7.911723   1.289598   1.818891  ...           0.279067   \n",
       "2  10.517330   5.114925  11.975349  11.911437  ...           0.219910   \n",
       "3  10.557465  13.304434   8.205059   9.211476  ...          -0.266554   \n",
       "4  12.964607   6.806517   4.294341   5.385714  ...          -0.441542   \n",
       "\n",
       "   pp_p70S6K  pp_p70S6K.pT389  pp_p90RSK  pp_p90RSK.pT359.S363  vital.status  \\\n",
       "0  -0.337863        -0.178503   0.011638             -0.207257             0   \n",
       "1   0.292925        -0.155242  -0.089365              0.267530             0   \n",
       "2   0.308110        -0.190794  -0.222150             -0.198518             0   \n",
       "3  -0.079871        -0.463237   0.522998             -0.046902             0   \n",
       "4  -0.152317         0.511386  -0.096482              0.037473             0   \n",
       "\n",
       "   PR.Status  ER.Status  HER2.Final.Status              histological.type  \n",
       "0   Positive   Positive           Negative  infiltrating ductal carcinoma  \n",
       "1   Positive   Negative           Negative  infiltrating ductal carcinoma  \n",
       "2   Positive   Positive           Negative  infiltrating ductal carcinoma  \n",
       "3   Positive   Positive           Negative  infiltrating ductal carcinoma  \n",
       "4   Positive   Positive           Negative  infiltrating ductal carcinoma  \n",
       "\n",
       "[5 rows x 1941 columns]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>DRUG_ID</th>\n",
       "      <th>COSMIC_ID</th>\n",
       "      <th>dose</th>\n",
       "      <th>viability</th>\n",
       "      <th>DATASET</th>\n",
       "      <th>ARXSPAN_ID</th>\n",
       "      <th>DRUG_NAME</th>\n",
       "      <th>BROAD_ID</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1007</td>\n",
       "      <td>924238</td>\n",
       "      <td>0.012500</td>\n",
       "      <td>0.183654</td>\n",
       "      <td>GDSC1</td>\n",
       "      <td>ACH-002148</td>\n",
       "      <td>DOCETAXEL</td>\n",
       "      <td>BRD-K30577245, BRD-A05821830, BRD-K63265447, B...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1007</td>\n",
       "      <td>924238</td>\n",
       "      <td>0.006250</td>\n",
       "      <td>0.104707</td>\n",
       "      <td>GDSC1</td>\n",
       "      <td>ACH-002148</td>\n",
       "      <td>DOCETAXEL</td>\n",
       "      <td>BRD-K30577245, BRD-A05821830, BRD-K63265447, B...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>1007</td>\n",
       "      <td>924238</td>\n",
       "      <td>0.003125</td>\n",
       "      <td>0.282676</td>\n",
       "      <td>GDSC1</td>\n",
       "      <td>ACH-002148</td>\n",
       "      <td>DOCETAXEL</td>\n",
       "      <td>BRD-K30577245, BRD-A05821830, BRD-K63265447, B...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>1007</td>\n",
       "      <td>924238</td>\n",
       "      <td>0.001563</td>\n",
       "      <td>0.325207</td>\n",
       "      <td>GDSC1</td>\n",
       "      <td>ACH-002148</td>\n",
       "      <td>DOCETAXEL</td>\n",
       "      <td>BRD-K30577245, BRD-A05821830, BRD-K63265447, B...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>1007</td>\n",
       "      <td>924238</td>\n",
       "      <td>0.000781</td>\n",
       "      <td>0.526366</td>\n",
       "      <td>GDSC1</td>\n",
       "      <td>ACH-002148</td>\n",
       "      <td>DOCETAXEL</td>\n",
       "      <td>BRD-K30577245, BRD-A05821830, BRD-K63265447, B...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   DRUG_ID  COSMIC_ID      dose  viability DATASET  ARXSPAN_ID  DRUG_NAME  \\\n",
       "0     1007     924238  0.012500   0.183654   GDSC1  ACH-002148  DOCETAXEL   \n",
       "1     1007     924238  0.006250   0.104707   GDSC1  ACH-002148  DOCETAXEL   \n",
       "2     1007     924238  0.003125   0.282676   GDSC1  ACH-002148  DOCETAXEL   \n",
       "3     1007     924238  0.001563   0.325207   GDSC1  ACH-002148  DOCETAXEL   \n",
       "4     1007     924238  0.000781   0.526366   GDSC1  ACH-002148  DOCETAXEL   \n",
       "\n",
       "                                            BROAD_ID  \n",
       "0  BRD-K30577245, BRD-A05821830, BRD-K63265447, B...  \n",
       "1  BRD-K30577245, BRD-A05821830, BRD-K63265447, B...  \n",
       "2  BRD-K30577245, BRD-A05821830, BRD-K63265447, B...  \n",
       "3  BRD-K30577245, BRD-A05821830, BRD-K63265447, B...  \n",
       "4  BRD-K30577245, BRD-A05821830, BRD-K63265447, B...  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "display(mutations_data.head(5))\n",
    "display(drug_sensitivity_data.head(5))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "13becd35-7ce3-497f-b9b2-a50e2a1de07a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 705 entries, 0 to 704\n",
      "Columns: 1941 entries, rs_CLEC3A to histological.type\n",
      "dtypes: float64(827), int64(1110), object(4)\n",
      "memory usage: 10.4+ MB\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "int64      1110\n",
       "float64     827\n",
       "object        4\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "mutations_data.info(verbose=False, show_counts=True)\n",
    "mutations_data.dtypes.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "71221e68-8941-4597-b9ac-cfa93abac842",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>0</th>\n",
       "      <th>1</th>\n",
       "      <th>2</th>\n",
       "      <th>3</th>\n",
       "      <th>4</th>\n",
       "      <th>5</th>\n",
       "      <th>6</th>\n",
       "      <th>7</th>\n",
       "      <th>8</th>\n",
       "      <th>9</th>\n",
       "      <th>...</th>\n",
       "      <th>1931</th>\n",
       "      <th>1932</th>\n",
       "      <th>1933</th>\n",
       "      <th>1934</th>\n",
       "      <th>1935</th>\n",
       "      <th>1936</th>\n",
       "      <th>1937</th>\n",
       "      <th>1938</th>\n",
       "      <th>1939</th>\n",
       "      <th>1940</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>name</th>\n",
       "      <td>rs_CLEC3A</td>\n",
       "      <td>rs_CPB1</td>\n",
       "      <td>rs_SCGB2A2</td>\n",
       "      <td>rs_SCGB1D2</td>\n",
       "      <td>rs_TFF1</td>\n",
       "      <td>rs_MUCL1</td>\n",
       "      <td>rs_GSTM1</td>\n",
       "      <td>rs_PIP</td>\n",
       "      <td>rs_ADIPOQ</td>\n",
       "      <td>rs_ADH1B</td>\n",
       "      <td>...</td>\n",
       "      <td>pp_p62.LCK.ligand</td>\n",
       "      <td>pp_p70S6K</td>\n",
       "      <td>pp_p70S6K.pT389</td>\n",
       "      <td>pp_p90RSK</td>\n",
       "      <td>pp_p90RSK.pT359.S363</td>\n",
       "      <td>vital.status</td>\n",
       "      <td>PR.Status</td>\n",
       "      <td>ER.Status</td>\n",
       "      <td>HER2.Final.Status</td>\n",
       "      <td>histological.type</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>dtype</th>\n",
       "      <td>float64</td>\n",
       "      <td>float64</td>\n",
       "      <td>float64</td>\n",
       "      <td>float64</td>\n",
       "      <td>float64</td>\n",
       "      <td>float64</td>\n",
       "      <td>float64</td>\n",
       "      <td>float64</td>\n",
       "      <td>float64</td>\n",
       "      <td>float64</td>\n",
       "      <td>...</td>\n",
       "      <td>float64</td>\n",
       "      <td>float64</td>\n",
       "      <td>float64</td>\n",
       "      <td>float64</td>\n",
       "      <td>float64</td>\n",
       "      <td>int64</td>\n",
       "      <td>object</td>\n",
       "      <td>object</td>\n",
       "      <td>object</td>\n",
       "      <td>object</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>non_null</th>\n",
       "      <td>705</td>\n",
       "      <td>705</td>\n",
       "      <td>705</td>\n",
       "      <td>705</td>\n",
       "      <td>705</td>\n",
       "      <td>705</td>\n",
       "      <td>705</td>\n",
       "      <td>705</td>\n",
       "      <td>705</td>\n",
       "      <td>705</td>\n",
       "      <td>...</td>\n",
       "      <td>705</td>\n",
       "      <td>705</td>\n",
       "      <td>705</td>\n",
       "      <td>705</td>\n",
       "      <td>705</td>\n",
       "      <td>705</td>\n",
       "      <td>583</td>\n",
       "      <td>583</td>\n",
       "      <td>560</td>\n",
       "      <td>705</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>null_pct</th>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>17.3</td>\n",
       "      <td>17.3</td>\n",
       "      <td>20.57</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>n_unique</th>\n",
       "      <td>522</td>\n",
       "      <td>672</td>\n",
       "      <td>691</td>\n",
       "      <td>680</td>\n",
       "      <td>666</td>\n",
       "      <td>683</td>\n",
       "      <td>667</td>\n",
       "      <td>684</td>\n",
       "      <td>678</td>\n",
       "      <td>670</td>\n",
       "      <td>...</td>\n",
       "      <td>705</td>\n",
       "      <td>704</td>\n",
       "      <td>701</td>\n",
       "      <td>705</td>\n",
       "      <td>705</td>\n",
       "      <td>2</td>\n",
       "      <td>5</td>\n",
       "      <td>5</td>\n",
       "      <td>4</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>example</th>\n",
       "      <td>0.892818</td>\n",
       "      <td>6.580103</td>\n",
       "      <td>14.123672</td>\n",
       "      <td>10.606501</td>\n",
       "      <td>13.189237</td>\n",
       "      <td>6.649466</td>\n",
       "      <td>10.520335</td>\n",
       "      <td>10.33849</td>\n",
       "      <td>10.248379</td>\n",
       "      <td>10.22997</td>\n",
       "      <td>...</td>\n",
       "      <td>-0.691766</td>\n",
       "      <td>-0.337863</td>\n",
       "      <td>-0.178503</td>\n",
       "      <td>0.011638</td>\n",
       "      <td>-0.207257</td>\n",
       "      <td>0</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Negative</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>6 rows × 1941 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "               0         1           2           3          4         5     \\\n",
       "name      rs_CLEC3A   rs_CPB1  rs_SCGB2A2  rs_SCGB1D2    rs_TFF1  rs_MUCL1   \n",
       "dtype       float64   float64     float64     float64    float64   float64   \n",
       "non_null        705       705         705         705        705       705   \n",
       "null_pct        0.0       0.0         0.0         0.0        0.0       0.0   \n",
       "n_unique        522       672         691         680        666       683   \n",
       "example    0.892818  6.580103   14.123672   10.606501  13.189237  6.649466   \n",
       "\n",
       "               6         7          8         9     ...               1931  \\\n",
       "name       rs_GSTM1    rs_PIP  rs_ADIPOQ  rs_ADH1B  ...  pp_p62.LCK.ligand   \n",
       "dtype       float64   float64    float64   float64  ...            float64   \n",
       "non_null        705       705        705       705  ...                705   \n",
       "null_pct        0.0       0.0        0.0       0.0  ...                0.0   \n",
       "n_unique        667       684        678       670  ...                705   \n",
       "example   10.520335  10.33849  10.248379  10.22997  ...          -0.691766   \n",
       "\n",
       "               1932             1933       1934                  1935  \\\n",
       "name      pp_p70S6K  pp_p70S6K.pT389  pp_p90RSK  pp_p90RSK.pT359.S363   \n",
       "dtype       float64          float64    float64               float64   \n",
       "non_null        705              705        705                   705   \n",
       "null_pct        0.0              0.0        0.0                   0.0   \n",
       "n_unique        704              701        705                   705   \n",
       "example   -0.337863        -0.178503   0.011638             -0.207257   \n",
       "\n",
       "                  1936       1937       1938               1939  \\\n",
       "name      vital.status  PR.Status  ER.Status  HER2.Final.Status   \n",
       "dtype            int64     object     object             object   \n",
       "non_null           705        583        583                560   \n",
       "null_pct           0.0       17.3       17.3              20.57   \n",
       "n_unique             2          5          5                  4   \n",
       "example              0   Positive   Positive           Negative   \n",
       "\n",
       "                                   1940  \n",
       "name                  histological.type  \n",
       "dtype                            object  \n",
       "non_null                            705  \n",
       "null_pct                            0.0  \n",
       "n_unique                              2  \n",
       "example   infiltrating ductal carcinoma  \n",
       "\n",
       "[6 rows x 1941 columns]"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cols = mutations_data.columns\n",
    "out = []\n",
    "\n",
    "for c in cols:\n",
    "    ser = mutations_data[c]\n",
    "    non_null = ser.notna().sum()\n",
    "    null_pct = 100.0 * (1.0 - non_null / max(len(mutations_data), 1))\n",
    "    try:\n",
    "        ex = ser.dropna().iloc[0]\n",
    "    except Exception:\n",
    "        ex = None\n",
    "        \n",
    "    out.append({\n",
    "        \"name\": c,\n",
    "        \"dtype\": str(ser.dtype),\n",
    "        \"non_null\": int(non_null),\n",
    "        \"null_pct\": round(null_pct, 2),\n",
    "        \"n_unique\": int(ser.nunique(dropna=True)),\n",
    "        \"example\": ex\n",
    "    })\n",
    "    \n",
    "table = pd.DataFrame(out).T\n",
    "table"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3e1837ac-614a-4457-8a6f-8295d13b8cee",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> The `mutations_data` table contains breast cancer patient samples with rich molecular and clinical annotations. Its shape reflects the number of tumor samples (rows) and the many features measured per sample (columns), including clinical subtype labels such as HER2, ER, and PR status, survival indicator, histological type, and quantitative pathway activity markers like `pp_HER2` and `pp_HER2.pY1248`. The first few rows demonstrate the format: each sample carries both its subtype label and the corresponding level of HER2 pathway activation, which will serve as the biological signal in the downstream analysis. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b691d32e-933d-4426-9c36-854ca909982f",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> The `drug_sensitivity_data` table captures in vitro drug response experiments. Each row is a single drug-cell line-dose measurement, with the drug identity (`DRUG_NAME`), the applied concentration (`dose`), and the resulting cell viability (`viability`). The preview shows raw survival fractions across different drugs and doses, which will be used to assess and compare the effectiveness of HER2-related (or proxy) targeted agents versus non-targeted comparators. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "61597acc-bec5-43d7-b86d-5857cf4b5c33",
   "metadata": {},
   "source": [
    "### 2.3. Immediate Observations and Next Steps"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6b66b524-5bc9-49fd-b38e-90ea70426ff0",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> From here, the next steps are to quantify the balance and quality of these data: count how many samples are labeled HER2-positive versus HER2-negative in `mutations_data`, and summarize the distribution of HER2 pathway activity within each group. In the drug data, identify the set of targeted versus comparator drugs, and compute basic summary statistics (like median viability) for each. This will establish the two analytical strands - tumor biology and drug response - that will later be integrated to test the central hypothesis. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "120f0abd-2e59-45e8-8f92-f519069f58a5",
   "metadata": {},
   "source": [
    "## 3. Data Preprocessing"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6be020b4-6c55-4215-889d-551a90fd334e",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> This section prepares both datasets for analysis: tumor biology (HER2 status and pathway activity) and drug response. The goal is to enforce consistency, create clean group definitions, normalize quantitative signals, and define the targeted vs comparator drug sets. Precise notation is introduced to make downstream hypotheses and tests unambiguous. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9d7da54d-b639-4cb3-b488-3c9c572802e2",
   "metadata": {},
   "source": [
    "### 3.1. Notation and Variables"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "be1444bc-3405-4250-8232-e9500c98fae6",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Let $i$ index patient tumor samples.  </p>\n",
    "\n",
    "<p style=\"font-size:18px;\"> Let $H_i \\in \\{0,1\\} $ be the binary HER2 status indicator:\n",
    "  $$\n",
    "  H_i = \n",
    "  \\begin{cases}\n",
    "    1 & \\text{if sample } i \\text{ is HER2-positive} \\\\\n",
    "    0 & \\text{if sample } i \\text{ is HER2-negative}\n",
    "  \\end{cases}\n",
    "  $$ </p>\n",
    "  \n",
    "<p style=\"font-size:18px;\"> Let $x_i$ denote the raw HER2 pathway activity measurement for sample $i$ (like `pp_HER2` or `pp_HER2.pY1248`). </p>\n",
    "                                                                                        \n",
    "<p style=\"font-size:18px;\"> Let $j$ index drug treatment experiments. For drug $j$, let $D_j$ be its name, $d_j$ the dose, and $ v_j$ the observed viability. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8613b253-e0a9-45b9-98fd-71f94eb65e49",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> We will define two drug categories. First one is: Targeted drugs $\\mathcal{T}$: agents acting on the HER2/HER-family axis or closest biological proxies (Lapatinib, Neratinib, EGFR inhibitors if exact HER2 inhibitors are absent). Next come Comparator drugs $\\mathcal{C}$: non-targeted standard treatments (Docetaxel) used as a baseline. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d20efee9-3fd5-41c8-a1e8-4da2d996a7af",
   "metadata": {},
   "source": [
    "### 3.2. Cleaning and Filtering"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "88c24b5c-001d-4e49-bdd3-f6bc37b9bb9c",
   "metadata": {},
   "source": [
    "#### 3.2.1. Mutations Data"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "95f6e8ff-c73c-4c98-95eb-4aa255eb3157",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Before any numeric transformation, we inspect and choose which columns will be used for the core analysis and which will be set aside (or used later as extensions). The dataset is wide; most features are not needed for the primary hypothesis, so we reduce complexity by keeping only what directly supports the test of HER2 signaling vs drug sensitivity. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7e26ea39-75b3-4ae6-8420-0be9bc3ef495",
   "metadata": {},
   "source": [
    "| Column / Prefix | Meaning (intuition) | Use in core analysis |\n",
    "|-----------------|---------------------|----------------------|\n",
    "| `HER2.Final.Status`, `ER.Status`, `PR.Status` | Clinical subtype labels (hormone receptor status) | **Keep** (grouping, context) |\n",
    "| `vital.status` | Outcome / survival indicator | Optional (exploratory) |\n",
    "| `histological.type` | Tumor histology | Optional (context / stratification) |\n",
    "| `pp_HER2`, `pp_HER2.pY1248` | HER2 protein level and activation (phosphorylation) | **Keep** (primary HER2 pathway signal) |\n",
    "| Other `pp_*` / phospho-variants | Protein signaling network components | Optional / extension |\n",
    "| `mu_*` | Mutation presence indicators (e.g., TP53, PIK3CA) | Optional (secondary depth/confounder checks) |\n",
    "| `cn_*` | Copy number variation | Deferred (not in core) |\n",
    "| `rs_*` | Likely expression or rescaled scores for many genes | Deferred (high-dimensional, for later exploration) |\n",
    "| Other miscellaneous columns | Various derived or gene-related signals | Deferred unless needed |"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "31f64acc-655d-4256-9a1a-36e9c0691347",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> `pp_*` columns are measurements of protein levels (or phosphorylation states) in each tumor sample. For example, pp_HER2 is the amount of HER2 protein. `pp_HER2.pY1248` is the activated (phosphorylated) form of HER2 at a specific site. Higher numbers mean more of that protein (or activated protein) was detected. We will compare averages or medians of these values between HER2+ and HER2- tumors to see if HER2+ really have more protein. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c511a46d-768f-4d45-8b1e-6937a33c4b6d",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> `mu_*` columns are mutation indicators for specific genes. Often these are 0 or 1, where 1 means \"we saw a mutation in this gene in that tumor\". </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "dbad0433-bbc6-4e00-bc5a-21f5cd5e68eb",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> `cn_*` columns are copy-number measures for genes - how many DNA copies of that gene are in the tumor. Values might be $\\log_2$ ratios (like 1.0 means twice as many copies; –1.0 means half as many). Or raw copy-number estimates (e.g. 3.2 copies on average). </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "00f6f318-9a6f-4d5b-a929-34ab6bbd5fcb",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> `rs_*` columns are gene-expression or \"rescaled\" scores for those genes - e.g. mRNA abundance measured on a microarray or RNA-seq. They're continuous and often on a log scale or normalized scale. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d27a9457-e412-44f7-86cb-1d2d8552cbeb",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> The full `mutations_data` contains thousands of measurements (`cn_*`, `rs_*`, `mu_*`, many `pp_*`), but our primary hypothesis hinges on just a few key variables: the clinical HER2 status (`HER2.Final.Status`) and its direct biological readouts (`pp_HER2` or `pp_HER2.pY1248`). By ignoring all other columns for now, we are left with: </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c74207dd-26da-403c-ade6-48330088fb82",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> HER2 status normalization - we will convert the clinical label `HER2.Final.Status` into the binary indicator $H_i$ by mapping \"Positive\" into 1, \"Negative\" into 0. Samples with missing, ambiguous, or non-standard status (like \"Equivocal\") are excluded to keep a clean two-group comparison. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4684e348-7551-4888-a8bb-660982532f86",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> We'll look at value counts for each of these columns, then apply simple cleaning (trim whitespace, unify case, map synonyms) if needed. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bfb1c79b-9167-446d-9a1c-7874340c762d",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Now I present the tumor dataset cleaning and vital-status encoding in code.<br>\n",
    "The function <code>clean_mutations()</code> takes: </p>\n",
    "<ul>\n",
    "  <li><b>mutations_df</b> – raw tumor dataframe.</li>\n",
    "  <li><b>signal_preference</b> – optional priority list for pathway columns (e.g., <code>['pp_her2','pp_her2_py1248']</code>).</li>\n",
    "</ul>\n",
    "<p style=\"font-size:18px;\"> The function <code>encode_vital_status()</code> takes: </p>\n",
    "<ul>\n",
    "  <li><b>df</b> – a dataframe that may contain a vital status column.</li>\n",
    "  <li><b>col</b> – the vital status column name to encode (default <code>\"vital_status\"</code>).</li>\n",
    "</ul>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "d2490732-9960-4068-a02d-851e2217d852",
   "metadata": {},
   "outputs": [],
   "source": [
    "mutations_data_clean, signal_col = u.clean_mutations(mutations_data)\n",
    "mutations_data_clean = u.encode_vital_status(mutations_data_clean, col=\"vital_status\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "19803514-ffc1-4747-8188-a73b4ddac093",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>her2_final_status</th>\n",
       "      <th>pp_her2</th>\n",
       "      <th>er_status</th>\n",
       "      <th>pr_status</th>\n",
       "      <th>vital_status</th>\n",
       "      <th>histological_type</th>\n",
       "      <th>H</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Negative</td>\n",
       "      <td>0.001087</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Positive</td>\n",
       "      <td>0</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Negative</td>\n",
       "      <td>0.532980</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Positive</td>\n",
       "      <td>0</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Negative</td>\n",
       "      <td>0.092221</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Positive</td>\n",
       "      <td>0</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Negative</td>\n",
       "      <td>0.076133</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Positive</td>\n",
       "      <td>0</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Negative</td>\n",
       "      <td>-0.699090</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Positive</td>\n",
       "      <td>0</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>644</th>\n",
       "      <td>Negative</td>\n",
       "      <td>-1.694630</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Positive</td>\n",
       "      <td>0</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>645</th>\n",
       "      <td>Negative</td>\n",
       "      <td>-1.038960</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>0</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>647</th>\n",
       "      <td>Positive</td>\n",
       "      <td>-0.100650</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Positive</td>\n",
       "      <td>0</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>648</th>\n",
       "      <td>Negative</td>\n",
       "      <td>0.179229</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Positive</td>\n",
       "      <td>0</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>649</th>\n",
       "      <td>Negative</td>\n",
       "      <td>-0.391634</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Positive</td>\n",
       "      <td>0</td>\n",
       "      <td>infiltrating lobular carcinoma</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>543 rows × 7 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    her2_final_status   pp_her2 er_status pr_status  vital_status  \\\n",
       "0            Negative  0.001087  Positive  Positive             0   \n",
       "1            Negative  0.532980  Negative  Positive             0   \n",
       "2            Negative  0.092221  Positive  Positive             0   \n",
       "3            Negative  0.076133  Positive  Positive             0   \n",
       "4            Negative -0.699090  Positive  Positive             0   \n",
       "..                ...       ...       ...       ...           ...   \n",
       "644          Negative -1.694630  Positive  Positive             0   \n",
       "645          Negative -1.038960  Negative  Negative             0   \n",
       "647          Positive -0.100650  Positive  Positive             0   \n",
       "648          Negative  0.179229  Positive  Positive             0   \n",
       "649          Negative -0.391634  Positive  Positive             0   \n",
       "\n",
       "                  histological_type  H  \n",
       "0     infiltrating ductal carcinoma  0  \n",
       "1     infiltrating ductal carcinoma  0  \n",
       "2     infiltrating ductal carcinoma  0  \n",
       "3     infiltrating ductal carcinoma  0  \n",
       "4     infiltrating ductal carcinoma  0  \n",
       "..                              ... ..  \n",
       "644   infiltrating ductal carcinoma  0  \n",
       "645   infiltrating ductal carcinoma  0  \n",
       "647   infiltrating ductal carcinoma  1  \n",
       "648   infiltrating ductal carcinoma  0  \n",
       "649  infiltrating lobular carcinoma  0  \n",
       "\n",
       "[543 rows x 7 columns]"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "mutations_data_clean"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "9ab2dbfa-4cf7-4319-8ea1-bdd5612e1d0a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Value counts for her2_final_status:\n",
      "her2_final_status\n",
      "Negative    457\n",
      "Positive     86\n",
      "Name: count, dtype: int64\n",
      "\n",
      "Value counts for pr_status:\n",
      "pr_status\n",
      "Positive                       332\n",
      "Negative                       177\n",
      "Not Performed                   28\n",
      "Indeterminate                    4\n",
      "Performed but Not Available      2\n",
      "Name: count, dtype: int64\n",
      "\n",
      "Value counts for vital_status:\n",
      "vital_status\n",
      "0    475\n",
      "1     68\n",
      "Name: count, dtype: int64\n",
      "\n",
      "Value counts for histological_type:\n",
      "histological_type\n",
      "infiltrating ductal carcinoma     492\n",
      "infiltrating lobular carcinoma     51\n",
      "Name: count, dtype: int64\n"
     ]
    }
   ],
   "source": [
    "# Categorical columns to check\n",
    "cat_cols = [\"her2_final_status\", \"E\", \"pr_status\", \"vital_status\", \"histological_type\"]\n",
    "\n",
    "for col in cat_cols:\n",
    "    if col in mutations_data_clean.columns:\n",
    "        print(f\"\\nValue counts for {col}:\")\n",
    "        print(mutations_data_clean[col].value_counts(dropna=False))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6b219bc3-0010-4976-866b-a84660497327",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Based on the value counts, ER and PR status include entries like \"Not Performed\" or \"Indeterminate\" that we don't want in our core grouping. </p>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "0ec36821-d724-461a-b015-5445ef0a5454",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Create binary indicators\n",
    "er = mutations_data_clean[\"er_status\"].astype(str).str.strip().str.lower()\n",
    "mutations_data_clean[\"E\"] = er.map({\n",
    "    \"positive\": 1, \"pos\": 1, \"er+\": 1,\n",
    "    \"negative\": 0, \"neg\": 0, \"er-\": 0\n",
    "}).astype(\"Int64\")\n",
    "\n",
    "pr = mutations_data_clean[\"pr_status\"].astype(str).str.strip().str.lower()\n",
    "mutations_data_clean[\"P\"] = pr.map({\n",
    "    \"positive\": 1, \"pos\": 1, \"pr+\": 1,\n",
    "    \"negative\": 0, \"neg\": 0, \"pr-\": 0\n",
    "}).astype(\"Int64\")\n",
    "\n",
    "mutations_data_clean = mutations_data_clean[mutations_data_clean[\"E\"].notna()]\n",
    "mutations_data_clean = mutations_data_clean[mutations_data_clean[\"P\"].notna()]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "b7831d44-2eee-4550-959e-e0d89dba5727",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "her2_final_status value counts:\n",
      "her2_final_status\n",
      "Negative    425\n",
      "Positive     82\n",
      "Name: count, dtype: int64\n",
      "\n",
      "pp_her2 value counts:\n",
      "pp_her2\n",
      "-0.391634    1\n",
      " 0.001087    1\n",
      " 0.532980    1\n",
      " 0.092221    1\n",
      " 0.076133    1\n",
      "            ..\n",
      "-0.186787    1\n",
      " 0.294261    1\n",
      "-0.716942    1\n",
      "-0.356237    1\n",
      "-0.810192    1\n",
      "Name: count, Length: 507, dtype: int64\n",
      "\n",
      "er_status value counts:\n",
      "er_status\n",
      "Positive    383\n",
      "Negative    124\n",
      "Name: count, dtype: int64\n",
      "\n",
      "pr_status value counts:\n",
      "pr_status\n",
      "Positive    331\n",
      "Negative    176\n",
      "Name: count, dtype: int64\n",
      "\n",
      "vital_status value counts:\n",
      "vital_status\n",
      "0    445\n",
      "1     62\n",
      "Name: count, dtype: int64\n",
      "\n",
      "histological_type value counts:\n",
      "histological_type\n",
      "infiltrating ductal carcinoma     457\n",
      "infiltrating lobular carcinoma     50\n",
      "Name: count, dtype: int64\n",
      "\n",
      "H value counts:\n",
      "H\n",
      "0    425\n",
      "1     82\n",
      "Name: count, dtype: int64\n",
      "\n",
      "E value counts:\n",
      "E\n",
      "1    383\n",
      "0    124\n",
      "Name: count, dtype: Int64\n",
      "\n",
      "P value counts:\n",
      "P\n",
      "1    331\n",
      "0    176\n",
      "Name: count, dtype: Int64\n"
     ]
    }
   ],
   "source": [
    "# Print value counts for each column to check for missing / inappropriate data\n",
    "for col in mutations_data_clean.columns:\n",
    "    print(f\"\\n{col} value counts:\")\n",
    "    print(mutations_data_clean[col].value_counts(dropna=False))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "28133be9-dc55-4f5f-9217-216b60d11db6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "her2_final_status     object\n",
       "pp_her2              float64\n",
       "er_status             object\n",
       "pr_status             object\n",
       "vital_status           int64\n",
       "histological_type     object\n",
       "H                      int64\n",
       "E                      Int64\n",
       "P                      Int64\n",
       "dtype: object"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "mutations_data_clean.dtypes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "53c91d76-2a9b-480c-b275-49ea3af140a3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>her2_final_status</th>\n",
       "      <th>pp_her2</th>\n",
       "      <th>er_status</th>\n",
       "      <th>pr_status</th>\n",
       "      <th>vital_status</th>\n",
       "      <th>histological_type</th>\n",
       "      <th>H</th>\n",
       "      <th>E</th>\n",
       "      <th>P</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Negative</td>\n",
       "      <td>0.001087</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Positive</td>\n",
       "      <td>0</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Negative</td>\n",
       "      <td>0.532980</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Positive</td>\n",
       "      <td>0</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Negative</td>\n",
       "      <td>0.092221</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Positive</td>\n",
       "      <td>0</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Negative</td>\n",
       "      <td>0.076133</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Positive</td>\n",
       "      <td>0</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Negative</td>\n",
       "      <td>-0.699090</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Positive</td>\n",
       "      <td>0</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>644</th>\n",
       "      <td>Negative</td>\n",
       "      <td>-1.694630</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Positive</td>\n",
       "      <td>0</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>645</th>\n",
       "      <td>Negative</td>\n",
       "      <td>-1.038960</td>\n",
       "      <td>Negative</td>\n",
       "      <td>Negative</td>\n",
       "      <td>0</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>647</th>\n",
       "      <td>Positive</td>\n",
       "      <td>-0.100650</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Positive</td>\n",
       "      <td>0</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>648</th>\n",
       "      <td>Negative</td>\n",
       "      <td>0.179229</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Positive</td>\n",
       "      <td>0</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>649</th>\n",
       "      <td>Negative</td>\n",
       "      <td>-0.391634</td>\n",
       "      <td>Positive</td>\n",
       "      <td>Positive</td>\n",
       "      <td>0</td>\n",
       "      <td>infiltrating lobular carcinoma</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>507 rows × 9 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    her2_final_status   pp_her2 er_status pr_status  vital_status  \\\n",
       "0            Negative  0.001087  Positive  Positive             0   \n",
       "1            Negative  0.532980  Negative  Positive             0   \n",
       "2            Negative  0.092221  Positive  Positive             0   \n",
       "3            Negative  0.076133  Positive  Positive             0   \n",
       "4            Negative -0.699090  Positive  Positive             0   \n",
       "..                ...       ...       ...       ...           ...   \n",
       "644          Negative -1.694630  Positive  Positive             0   \n",
       "645          Negative -1.038960  Negative  Negative             0   \n",
       "647          Positive -0.100650  Positive  Positive             0   \n",
       "648          Negative  0.179229  Positive  Positive             0   \n",
       "649          Negative -0.391634  Positive  Positive             0   \n",
       "\n",
       "                  histological_type  H  E  P  \n",
       "0     infiltrating ductal carcinoma  0  1  1  \n",
       "1     infiltrating ductal carcinoma  0  0  1  \n",
       "2     infiltrating ductal carcinoma  0  1  1  \n",
       "3     infiltrating ductal carcinoma  0  1  1  \n",
       "4     infiltrating ductal carcinoma  0  1  1  \n",
       "..                              ... .. .. ..  \n",
       "644   infiltrating ductal carcinoma  0  1  1  \n",
       "645   infiltrating ductal carcinoma  0  0  0  \n",
       "647   infiltrating ductal carcinoma  1  1  1  \n",
       "648   infiltrating ductal carcinoma  0  1  1  \n",
       "649  infiltrating lobular carcinoma  0  1  1  \n",
       "\n",
       "[507 rows x 9 columns]"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "mutations_data_clean"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "5e19a99c-4854-4dc4-ae93-4e7c50980768",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Post‐filter shape: (507, 9)\n",
      "pp_her2    0\n",
      "H          0\n",
      "E          0\n",
      "P          0\n",
      "dtype: int64\n"
     ]
    }
   ],
   "source": [
    "# Check for presence of NaN values\n",
    "print(\"Post‐filter shape:\", mutations_data_clean.shape)\n",
    "print(mutations_data_clean[[signal_col, \"H\", \"E\", \"P\"]].isna().sum())"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0c220a00-e705-4557-8066-dd7e1517da12",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> At this stage, the mutations dataset has been cleaned to include only standardized HER2, ER, and PR status labels, binary receptor indicators, and the primary HER2 pathway activity measurement, with all other columns removed. Our mutations data looks fully clean (543 samples with no missing core values). Let's complete the drug side, but before that, a little evidence for our choices! </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "02b80250-fc2c-43dd-9f82-d82ba2ea8e57",
   "metadata": {},
   "source": [
    "#### 3.2.2. Why these columns (evidence-based rationale)?"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "283291af-3afd-46d3-857e-a9d2096df776",
   "metadata": {},
   "source": [
    "<p style=\"font-size:22px;\"> A) Study aim & pre-specification </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ba2fe6db-c2ce-4086-857f-a148931f34bb",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Our hypotheses target three constructs: (i) HER2 pathway activity in the tumor (pp_HER2), (ii) clinical HER2 label (her2_final_status), (iii) drug potency in vitro (viability). To avoid a \"garden of forking paths\" and inflated false positives, we pre-specified analyses using variables that directly instantiate those constructs. Everything else was evaluated against the criteria below and excluded if it did not improve construct validity or would require a different modeling design. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "da3ec387-fd38-4613-bdee-ae98c5da6891",
   "metadata": {},
   "source": [
    "<p style=\"font-size:22px;\"> B) Inclusion criteria (what we kept) </p> "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b5aaadb3-9280-4816-99d6-f48580aab8d2",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Primary signal: pp_HER2 (or pp_HER2_pY1248) as the HER2 pathway readout; Labels: her2_final_status, er_status, pr_status (Positive/Negative); Outcome proxy: vital_status encoded 0=alive/1=deceased; Drug response: drug_name, dose, viability (fraction 0-1), cosmic_id for per-line aggregation. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "04f5bd80-3058-44dc-bd09-ea603065aeb8",
   "metadata": {},
   "source": [
    "<p style=\"font-size:22px;\"> C) Exclusion criteria (what and why we removed) </p> "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d3cb41a4-62bb-4388-b2a5-3534513927fa",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Our tumor (mutations) table had 705 samples x 1,941 columns. It contained a handful of clinical labels (HER2/ER/PR/vital status/histology) plus several large feature blocks: 223 phospho/protein \"pp_\" signals (including pp_HER2 and pp_HER2.pY1248), 604 expression-like \"rs_\" features, 860 copy-number \"cn_\" features, and 249 per-gene mutation flags (\"mu_\"). We kept exactly the five fields that instantiate our hypotheses - pp_HER2 (pathway activity), HER2.Final.Status, ER.Status, PR.Status, and vital.status - because they are the minimal set needed to test (i) survival vs pathway activity, (ii) targeted vs comparator drug potency (via linking to cell lines), and (iii) concordance of clinical HER2 status with pathway level. Everything else was evaluated against the evidence below."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "3aa6779c-dad3-436a-9223-97c6d2083e87",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Blocks by prefix - pp_: 223, rs_: 604, cn_: 860, mu_: 249\n"
     ]
    }
   ],
   "source": [
    "pp_cnt = sum(c.lower().startswith(\"pp_\") for c in mutations_data.columns)\n",
    "rs_cnt = sum(c.lower().startswith(\"rs_\") for c in mutations_data.columns)\n",
    "cn_cnt = sum(c.lower().startswith(\"cn_\") for c in mutations_data.columns)\n",
    "mu_cnt = sum(c.lower().startswith(\"mu_\") for c in mutations_data.columns)\n",
    "print(f\"Blocks by prefix - pp_: {pp_cnt}, rs_: {rs_cnt}, cn_: {cn_cnt}, mu_: {mu_cnt}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f7babf6b-2f18-4dd4-bfbe-5b2c62d313aa",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> There are two HER2 pathway columns: pp_HER2 and pp_HER2.pY1248. On complete cases they are strongly correlated (r = 0.854). Keeping both would double-encode the same construct and blur interpretation. We therefore pre-specify pp_HER2 as canonical, while noting that substituting pY1248 would not change the qualitative direction implied by this correlation. </p>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "ce6821fb-374b-43aa-aca6-06b2403c8833",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Complete pairs: 705\n",
      "Correlation r(pp_HER2, pp_HER2.pY1248): 0.854\n"
     ]
    }
   ],
   "source": [
    "pp1, pp2 = \"pp_HER2\", \"pp_HER2.pY1248\"\n",
    "\n",
    "if pp1 in mutations_data.columns and pp2 in mutations_data.columns:\n",
    "    a = pd.to_numeric(mutations_data[pp1], errors=\"coerce\")\n",
    "    b = pd.to_numeric(mutations_data[pp2], errors=\"coerce\")\n",
    "    mask = a.notna() & b.notna()\n",
    "    print(\"Complete pairs:\", int(mask.sum()))\n",
    "    print(\"Correlation r(pp_HER2, pp_HER2.pY1248):\", round(a[mask].corr(b[mask]), 3))\n",
    "else:\n",
    "    print(\"Alternative HER2 signal not available to compare.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "977e28f8-bb50-4655-8abd-80789325f908",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> The clinical fields are not purely binary. For ER.Status, only Positive (414) and Negative (135) are binary; 22% are \"NA / Not Performed / Performed but Not Available / Indeterminate\". PR.Status shows 23% non-binary or missing; HER2.Final.Status has 23.0% non-binary/missing (\"Equivocal\", \"Not Available\"). To avoid bias, we analyze Positive vs Negative and treat the rest as missing rather than coding them as true negatives. Receipts: the audit cell prints the top counts for each label along with the non-binary/NA share for ER (22%), PR (23%), and HER2 (23%). </p>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "3c31d026-4100-4293-aa01-06029fad3611",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "ER.Status counts (top):\n",
      "ER.Status\n",
      "Positive                       414\n",
      "Negative                       135\n",
      "NaN                            122\n",
      "Not Performed                   27\n",
      "Performed but Not Available      5\n",
      "Indeterminate                    2\n",
      "Name: count, dtype: int64\n",
      "Non-binary/NA share for ER.Status: 22.1%\n",
      "\n",
      "PR.Status counts (top):\n",
      "PR.Status\n",
      "Positive                       353\n",
      "Negative                       193\n",
      "NaN                            122\n",
      "Not Performed                   28\n",
      "Performed but Not Available      5\n",
      "Indeterminate                    4\n",
      "Name: count, dtype: int64\n",
      "Non-binary/NA share for PR.Status: 22.6%\n",
      "\n",
      "HER2.Final.Status counts (top):\n",
      "HER2.Final.Status\n",
      "Negative         457\n",
      "NaN              145\n",
      "Positive          86\n",
      "Equivocal          9\n",
      "Not Available      8\n",
      "Name: count, dtype: int64\n",
      "Non-binary/NA share for HER2.Final.Status: 23.0%\n"
     ]
    }
   ],
   "source": [
    "for col in [\"ER.Status\", \"PR.Status\", \"HER2.Final.Status\"]:\n",
    "    if col not in mutations_data.columns:\n",
    "        print(f\"{col} not present.\")\n",
    "        continue\n",
    "    vc = mutations_data[col].value_counts(dropna=False)\n",
    "    print(f\"\\n{col} counts (top):\")\n",
    "    print(vc.head(10))\n",
    "\n",
    "    allowed = {\"positive\", \"negative\"}\n",
    "    nonbin = mutations_data[col].astype(str).str.strip().str.lower().map(lambda x: x not in allowed).sum()\n",
    "    pct = nonbin / len(mutations_data)\n",
    "    print(f\"Non-binary/NA share for {col}: {pct:.1%}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e0c1f69c-7dbb-4d64-848e-0e14ba8e0638",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Histology is tidy with two levels: infiltrating ductal carcinoma (n=574) and infiltrating lobular carcinoma (n=131). The HER2-positive rate differs: ductal 17% (84/574) vs lobular 4% (2/131). Because histology is a determinant of HER2 labeling here, including it as a covariate would shift the primary target from an unadjusted association to an adjusted effect (a different estimand that should be pre-declared). We therefore keep histology for EDA and, if requested, run a clearly labeled sensitivity model (vital_status $\\sim$ z(pp_HER2) + histology) rather than co-mix it with the primary tests. </p>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "66792118-6411-4de0-b2ff-047e0db5d9f4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Histology levels (top):\n",
      "histological.type\n",
      "infiltrating ductal carcinoma     574\n",
      "infiltrating lobular carcinoma    131\n",
      "Name: count, dtype: int64\n",
      "\n",
      "HER2+ rate by histology:\n",
      "histological.type\n",
      "infiltrating ductal carcinoma     16.5%\n",
      "infiltrating lobular carcinoma     3.9%\n",
      "dtype: object\n"
     ]
    }
   ],
   "source": [
    "if {\"histological.type\",\"HER2.Final.Status\"}.issubset(mutations_data.columns):\n",
    "    hist_counts = mutations_data[\"histological.type\"].astype(str).str.strip().value_counts(dropna=False)\n",
    "    print(\"Histology levels (top):\")\n",
    "    print(hist_counts.head(10))\n",
    "\n",
    "    ct = pd.crosstab(mutations_data[\"histological.type\"], mutations_data[\"HER2.Final.Status\"])\n",
    "    if \"Positive\" in ct.columns:\n",
    "        rates = (ct[\"Positive\"] / ct.sum(axis=1)).sort_values(ascending=False)\n",
    "        print(\"\\nHER2+ rate by histology:\")\n",
    "        print((rates*100).round(1).astype(str) + \"%\")\n",
    "    else:\n",
    "        print(\"\\nNo 'Positive' column in HER2.Final.Status to compute rates.\")\n",
    "else:\n",
    "    print(\"Histology or HER2 status column missing.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "93d9b090-f5ec-4bb3-b607-6406537961d6",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Across the 249 mutation indicators (mu_*), the mean prevalence is 3% and median 2.4%; 230/249 genes have < 5% positives. Flooding the model with dozens of ultra-rare binaries risks quasi-separation and requires a multiple-testing framework. We exclude mu_* from confirmatory tests; they are suitable for a separate exploratory analysis. </p>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "6c0b0b79-c8d2-43fe-bd48-218f98810886",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of mutation flag columns: 249\n",
      "Mean prevalence: 3.118% | Median prevalence: 2.411%\n",
      "Columns < 5% mutated: 230\n",
      "Columns < 1% mutated: 0\n"
     ]
    }
   ],
   "source": [
    "mu_cols = [c for c in mutations_data.columns if c.lower().startswith(\"mu_\")]\n",
    "if mu_cols:\n",
    "    # Treat any non-zero as mutated\n",
    "    prev = (mutations_data[mu_cols] != 0).sum(axis=0) / len(mutations_data)\n",
    "    print(\"Number of mutation flag columns:\", len(mu_cols))\n",
    "    print(\"Mean prevalence:\", f\"{prev.mean():.3%}\", \"| Median prevalence:\", f\"{prev.median():.3%}\")\n",
    "    print(\"Columns < 5% mutated:\", int((prev < 0.05).sum()))\n",
    "    print(\"Columns < 1% mutated:\", int((prev < 0.01).sum()))\n",
    "else:\n",
    "    print(\"No mu_* columns found.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d8f79288-3212-4ab3-873e-bc610ac71d6a",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> The 860 cn_* and 604 rs_* features are valuable for broader omics exploration, but using them here would convert the study into a high-dimensional modeling exercise and risks adjusting away HER2-mediated biology. We keep the analysis focused on the single, pre-specified HER2 pathway readout and clinical labels to avoid a forking-paths problem. That is the final part of the Mutations Data Cleaning Process! Lets start with the Drug Data!"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cc51c6fd-865a-4045-bd94-f0614cba71e7",
   "metadata": {},
   "source": [
    "#### 3.2.3. Drug Data"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "38be66a6-beed-4367-9616-f7d8142626f4",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Let's move onto drug sensitivy data. We normalize, drop missing critical fields, filter, etc. </p>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "1a141802-5015-43b3-877a-c6019c2f84d4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>name</th>\n",
       "      <th>dtype</th>\n",
       "      <th>non_null</th>\n",
       "      <th>null_pct</th>\n",
       "      <th>n_unique</th>\n",
       "      <th>example</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>DRUG_ID</td>\n",
       "      <td>int64</td>\n",
       "      <td>4049857</td>\n",
       "      <td>0.00</td>\n",
       "      <td>453</td>\n",
       "      <td>1007</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>COSMIC_ID</td>\n",
       "      <td>int64</td>\n",
       "      <td>4049857</td>\n",
       "      <td>0.00</td>\n",
       "      <td>990</td>\n",
       "      <td>924238</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>dose</td>\n",
       "      <td>float64</td>\n",
       "      <td>4049857</td>\n",
       "      <td>0.00</td>\n",
       "      <td>279</td>\n",
       "      <td>0.0125</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>viability</td>\n",
       "      <td>float64</td>\n",
       "      <td>4049857</td>\n",
       "      <td>0.00</td>\n",
       "      <td>2454751</td>\n",
       "      <td>0.183654</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>DATASET</td>\n",
       "      <td>object</td>\n",
       "      <td>4049857</td>\n",
       "      <td>0.00</td>\n",
       "      <td>2</td>\n",
       "      <td>GDSC1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>ARXSPAN_ID</td>\n",
       "      <td>object</td>\n",
       "      <td>3950441</td>\n",
       "      <td>2.45</td>\n",
       "      <td>974</td>\n",
       "      <td>ACH-002148</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>DRUG_NAME</td>\n",
       "      <td>object</td>\n",
       "      <td>4049857</td>\n",
       "      <td>0.00</td>\n",
       "      <td>397</td>\n",
       "      <td>DOCETAXEL</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>BROAD_ID</td>\n",
       "      <td>object</td>\n",
       "      <td>3152495</td>\n",
       "      <td>22.16</td>\n",
       "      <td>286</td>\n",
       "      <td>BRD-K30577245, BRD-A05821830, BRD-K63265447, B...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         name    dtype  non_null  null_pct  n_unique  \\\n",
       "0     DRUG_ID    int64   4049857      0.00       453   \n",
       "1   COSMIC_ID    int64   4049857      0.00       990   \n",
       "2        dose  float64   4049857      0.00       279   \n",
       "3   viability  float64   4049857      0.00   2454751   \n",
       "4     DATASET   object   4049857      0.00         2   \n",
       "5  ARXSPAN_ID   object   3950441      2.45       974   \n",
       "6   DRUG_NAME   object   4049857      0.00       397   \n",
       "7    BROAD_ID   object   3152495     22.16       286   \n",
       "\n",
       "                                             example  \n",
       "0                                               1007  \n",
       "1                                             924238  \n",
       "2                                             0.0125  \n",
       "3                                           0.183654  \n",
       "4                                              GDSC1  \n",
       "5                                         ACH-002148  \n",
       "6                                          DOCETAXEL  \n",
       "7  BRD-K30577245, BRD-A05821830, BRD-K63265447, B...  "
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cols = drug_sensitivity_data.columns\n",
    "out = []\n",
    "\n",
    "for c in cols:\n",
    "    ser = drug_sensitivity_data[c]\n",
    "    non_null = ser.notna().sum()\n",
    "    null_pct = 100.0 * (1.0 - non_null / max(len(drug_sensitivity_data), 1))\n",
    "    try:\n",
    "        ex = ser.dropna().iloc[0]\n",
    "    except Exception:\n",
    "        ex = None\n",
    "        \n",
    "    out.append({\n",
    "        \"name\": c,\n",
    "        \"dtype\": str(ser.dtype),\n",
    "        \"non_null\": int(non_null),\n",
    "        \"null_pct\": round(null_pct, 2),\n",
    "        \"n_unique\": int(ser.nunique(dropna=True)),\n",
    "        \"example\": ex\n",
    "    })\n",
    "    \n",
    "table = pd.DataFrame(out)\n",
    "table"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5f6cc1bb-1e9b-48ef-a0e5-afc9e335619b",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Now I present the drug dataset cleaning and numeric validation for it in code.<br>\n",
    "The function <code>clean_drugs()</code> takes: </p>\n",
    "<ul>\n",
    "  <li><b>drug_df</b> – raw drug sensitivity dataframe.</li>\n",
    "</ul>\n",
    "<p style=\"font-size:18px;\"> The function <code>validate_drugs_numeric()</code> takes: </p>\n",
    "<ul>\n",
    "  <li><b>df</b> – cleaned drug dataframe (after <code>clean_drugs()</code>).</li>\n",
    "  <li><b>clip_viability</b> – lower/upper bounds to clip viability (default <code>(0, 200)</code>).</li>\n",
    "  <li><b>min_dose</b> – minimum allowed dose value (default <code>0</code>).</li>\n",
    "  <li><b>keep_zero_dose</b> – keep rows where dose equals 0 (default <code>True</code>).</li>\n",
    "</ul>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "f6efefda-0db1-4c79-8500-e21f6121cc29",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>cosmic_id</th>\n",
       "      <th>drug_name</th>\n",
       "      <th>dose</th>\n",
       "      <th>viability</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>924238</td>\n",
       "      <td>docetaxel</td>\n",
       "      <td>0.012500</td>\n",
       "      <td>0.183654</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>924238</td>\n",
       "      <td>docetaxel</td>\n",
       "      <td>0.006250</td>\n",
       "      <td>0.104707</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>924238</td>\n",
       "      <td>docetaxel</td>\n",
       "      <td>0.003125</td>\n",
       "      <td>0.282676</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>924238</td>\n",
       "      <td>docetaxel</td>\n",
       "      <td>0.001563</td>\n",
       "      <td>0.325207</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>924238</td>\n",
       "      <td>docetaxel</td>\n",
       "      <td>0.000781</td>\n",
       "      <td>0.526366</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4049852</th>\n",
       "      <td>908120</td>\n",
       "      <td>sb-216763</td>\n",
       "      <td>0.039062</td>\n",
       "      <td>0.941186</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4049853</th>\n",
       "      <td>908120</td>\n",
       "      <td>sb-216763</td>\n",
       "      <td>0.009766</td>\n",
       "      <td>0.980837</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4049854</th>\n",
       "      <td>908120</td>\n",
       "      <td>ku-55933</td>\n",
       "      <td>2.500000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4049855</th>\n",
       "      <td>908120</td>\n",
       "      <td>ku-55933</td>\n",
       "      <td>5.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4049856</th>\n",
       "      <td>908120</td>\n",
       "      <td>ku-55933</td>\n",
       "      <td>10.000000</td>\n",
       "      <td>0.937246</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>4049857 rows × 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "         cosmic_id  drug_name       dose  viability\n",
       "0           924238  docetaxel   0.012500   0.183654\n",
       "1           924238  docetaxel   0.006250   0.104707\n",
       "2           924238  docetaxel   0.003125   0.282676\n",
       "3           924238  docetaxel   0.001563   0.325207\n",
       "4           924238  docetaxel   0.000781   0.526366\n",
       "...            ...        ...        ...        ...\n",
       "4049852     908120  sb-216763   0.039062   0.941186\n",
       "4049853     908120  sb-216763   0.009766   0.980837\n",
       "4049854     908120   ku-55933   2.500000   1.000000\n",
       "4049855     908120   ku-55933   5.000000   1.000000\n",
       "4049856     908120   ku-55933  10.000000   0.937246\n",
       "\n",
       "[4049857 rows x 4 columns]"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_data_clean = u.clean_drugs(drug_sensitivity_data)\n",
    "drug_data_clean = u.validate_drugs_numeric(drug_data_clean)\n",
    "drug_data_clean"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "cd39a93f-eae1-4b05-95f0-ec483fd8e3c4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "cosmic_id      int64\n",
       "drug_name     object\n",
       "dose         float64\n",
       "viability    float64\n",
       "dtype: object"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_data_clean.dtypes"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5b35c455-8209-46e4-910b-9384a7f9391c",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Before we trim the drug‐sensitivity table down to its essential four columns, it's worth pausing to consider why each of the other fields isn't needed for our core analyses. Columns like `DRUG_ID`, `ARXSPAN_ID`, and `BROAD_ID` are simply alternate identifiers for the same compound - they don't add new biological information beyond the human‐readable `DRUG_NAME`. Likewise, `DATASET` tells us which source the measurement came from, which can be important for bookkeeping later but isn't required for now. By focusing on `COSMIC_ID` (a unique identifier for a cancer cell line in the COSMIC database - short for the Catalogue Of Somatic Mutations In Cancer), `DRUG_NAME` (our grouping variable), `dose` (the independent variable), and `viability` (the dependent response), we avoid unnecessary complexity. </p>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "db4abdf7-bf92-49dc-8e26-78f22383a58f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "cosmic_id value counts:\n",
      "cosmic_id\n",
      "905962     26702\n",
      "753608     25926\n",
      "906793     25463\n",
      "905939     25091\n",
      "906830     23869\n",
      "           ...  \n",
      "1331030      387\n",
      "753597       369\n",
      "924189       225\n",
      "949092       225\n",
      "688022        18\n",
      "Name: count, Length: 990, dtype: int64\n",
      "\n",
      "drug_name value counts:\n",
      "drug_name\n",
      "afatinib      45417\n",
      "linsitinib    37229\n",
      "plx-4720      33620\n",
      "pd-0325901    33604\n",
      "docetaxel     32793\n",
      "              ...  \n",
      "zg-10          2845\n",
      "hg-5-88-01     2841\n",
      "xmd11-85h      2780\n",
      "ql-xii-61      2642\n",
      "ribociclib     1176\n",
      "Name: count, Length: 397, dtype: int64\n",
      "\n",
      "dose value counts:\n",
      "dose\n",
      "10.000000    215554\n",
      "2.500000     129394\n",
      "0.625000     125528\n",
      "5.000000     124156\n",
      "0.156250     124043\n",
      "              ...  \n",
      "0.187500         21\n",
      "1.500000         20\n",
      "0.023438         20\n",
      "0.046875         19\n",
      "0.093750         19\n",
      "Name: count, Length: 279, dtype: int64\n",
      "\n",
      "viability value counts:\n",
      "viability\n",
      "1.000000    1110212\n",
      "0.000000       3873\n",
      "0.925330         24\n",
      "0.961558         24\n",
      "0.973633         20\n",
      "             ...   \n",
      "0.945168          1\n",
      "0.913439          1\n",
      "0.988759          1\n",
      "0.980837          1\n",
      "0.937246          1\n",
      "Name: count, Length: 2454751, dtype: int64\n"
     ]
    }
   ],
   "source": [
    "for col in drug_data_clean.columns:\n",
    "    print(f\"\\n{col} value counts:\")\n",
    "    print(drug_data_clean[col].value_counts(dropna=False))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "e810da6c-1078-4bc5-bdf0-1b66bafcf24f",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Ensure viability is on [0,1] (convert % -> fraction if needed)\n",
    "q90 = drug_data_clean[\"viability\"].dropna().quantile(0.9)\n",
    "if q90 > 1.5:\n",
    "    drug_data_clean[\"viability\"] = drug_data_clean[\"viability\"] / 100.0"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "faee2b4e-d1cb-4ca4-a04a-a93c061af086",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>cosmic_id</th>\n",
       "      <th>drug_name</th>\n",
       "      <th>dose</th>\n",
       "      <th>viability</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>924238</td>\n",
       "      <td>docetaxel</td>\n",
       "      <td>0.012500</td>\n",
       "      <td>0.183654</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>924238</td>\n",
       "      <td>docetaxel</td>\n",
       "      <td>0.006250</td>\n",
       "      <td>0.104707</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>924238</td>\n",
       "      <td>docetaxel</td>\n",
       "      <td>0.003125</td>\n",
       "      <td>0.282676</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>924238</td>\n",
       "      <td>docetaxel</td>\n",
       "      <td>0.001563</td>\n",
       "      <td>0.325207</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>924238</td>\n",
       "      <td>docetaxel</td>\n",
       "      <td>0.000781</td>\n",
       "      <td>0.526366</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4049852</th>\n",
       "      <td>908120</td>\n",
       "      <td>sb-216763</td>\n",
       "      <td>0.039062</td>\n",
       "      <td>0.941186</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4049853</th>\n",
       "      <td>908120</td>\n",
       "      <td>sb-216763</td>\n",
       "      <td>0.009766</td>\n",
       "      <td>0.980837</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4049854</th>\n",
       "      <td>908120</td>\n",
       "      <td>ku-55933</td>\n",
       "      <td>2.500000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4049855</th>\n",
       "      <td>908120</td>\n",
       "      <td>ku-55933</td>\n",
       "      <td>5.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4049856</th>\n",
       "      <td>908120</td>\n",
       "      <td>ku-55933</td>\n",
       "      <td>10.000000</td>\n",
       "      <td>0.937246</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>4049857 rows × 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "         cosmic_id  drug_name       dose  viability\n",
       "0           924238  docetaxel   0.012500   0.183654\n",
       "1           924238  docetaxel   0.006250   0.104707\n",
       "2           924238  docetaxel   0.003125   0.282676\n",
       "3           924238  docetaxel   0.001563   0.325207\n",
       "4           924238  docetaxel   0.000781   0.526366\n",
       "...            ...        ...        ...        ...\n",
       "4049852     908120  sb-216763   0.039062   0.941186\n",
       "4049853     908120  sb-216763   0.009766   0.980837\n",
       "4049854     908120   ku-55933   2.500000   1.000000\n",
       "4049855     908120   ku-55933   5.000000   1.000000\n",
       "4049856     908120   ku-55933  10.000000   0.937246\n",
       "\n",
       "[4049857 rows x 4 columns]"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_data_clean"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2dd42612-43c4-4395-a24b-9f69e257f1d0",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> With these steps complete, both of our core datasets are now fully cleaned and harmonized for downstream analysis. In the mutations table, we normalized and filtered `HER2` labels to only \"Positive\" or \"Negative\" created binary indicators (`H` and `E`), selected and de-duplicated the primary HER2 pathway signal (`pp_her2` or `pp_her2_py1248`), and carried forward contextual columns for `ER/PR status`, `survival`, and `histology` - dropping any samples with missing key values. In the drug-sensitivity table, we standardized `drug_name` and retained only the essential identifiers (`cosmic_id`). All columns have been converted to clean snake_case, and every row now contains exactly the information we need. With no remaining missing or malformed values in these critical fields, we are finished. We print a report to check out if we missed anything. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "76464f37-9123-4fde-bdf8-19e98a9dd68e",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Now I present the missingness snapshot in code.<br>\n",
    "The function <code>missingness_report()</code> takes: </p>\n",
    "<ul>\n",
    "  <li><b>df</b> – any dataframe (mutations or drug).</li>\n",
    "  <li><b>top_n</b> – how many rows (columns) to show, ordered by missingness (default <code>25</code>).</li>\n",
    "</ul>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "ae884128-1bdc-4835-9148-8dbc72234731",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>column</th>\n",
       "      <th>null_pct</th>\n",
       "      <th>n_unique</th>\n",
       "      <th>example</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>her2_final_status</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2</td>\n",
       "      <td>Negative</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>pp_her2</td>\n",
       "      <td>0.0</td>\n",
       "      <td>507</td>\n",
       "      <td>0.001087</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>er_status</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2</td>\n",
       "      <td>Positive</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>pr_status</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2</td>\n",
       "      <td>Positive</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>vital_status</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>histological_type</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2</td>\n",
       "      <td>infiltrating ductal carcinoma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>H</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>E</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>P</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "              column  null_pct  n_unique                        example\n",
       "0  her2_final_status       0.0         2                       Negative\n",
       "1            pp_her2       0.0       507                       0.001087\n",
       "2          er_status       0.0         2                       Positive\n",
       "3          pr_status       0.0         2                       Positive\n",
       "4       vital_status       0.0         2                              0\n",
       "5  histological_type       0.0         2  infiltrating ductal carcinoma\n",
       "6                  H       0.0         2                              0\n",
       "7                  E       0.0         2                              1\n",
       "8                  P       0.0         2                              1"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>column</th>\n",
       "      <th>null_pct</th>\n",
       "      <th>n_unique</th>\n",
       "      <th>example</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>cosmic_id</td>\n",
       "      <td>0.0</td>\n",
       "      <td>990</td>\n",
       "      <td>924238</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>drug_name</td>\n",
       "      <td>0.0</td>\n",
       "      <td>397</td>\n",
       "      <td>docetaxel</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>dose</td>\n",
       "      <td>0.0</td>\n",
       "      <td>279</td>\n",
       "      <td>0.0125</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>viability</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2454751</td>\n",
       "      <td>0.183654</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "      column  null_pct  n_unique    example\n",
       "0  cosmic_id       0.0       990     924238\n",
       "1  drug_name       0.0       397  docetaxel\n",
       "2       dose       0.0       279     0.0125\n",
       "3  viability       0.0   2454751   0.183654"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "display(u.missingness_report(mutations_data_clean, top_n=20))\n",
    "display(u.missingness_report(drug_data_clean, top_n=20))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3e60755d-834e-4e13-9876-32037cca83eb",
   "metadata": {},
   "source": [
    "#### 3.2.4. Why did we clean it this way?"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "97f9eaa7-4d6b-46f6-bc51-974ff27a1589",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Our drug file contains 4 049 857 rows x 8 columns. The analytical signal is fully captured by COSMIC_ID, DRUG_NAME, dose, and viability. We verified the viability scale is [0.0, 1.0] with 3873 zeros, 1110212 ones, and median 0.926; dose has 279 unique values with no negatives and no zero-dose rows (so \"controls\" must be identified by naming rather than dose==0). The remaining fields are identifiers/metadata: BROAD_ID (77.84% non-null, 286 uniques), ARXSPAN_ID (97.5% non-null, 974 uniques), and DATASET (two levels: GDSC1, GDSC2). These are useful for bookkeeping, not for potency inference."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "9ff7e8a0-146d-4e76-a1ce-0a2bfa1b1341",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Drug rows: 4,049,857\n",
      "Viability range: [0, 1] | zeros: 3,873 | ones: 1,110,212 | median: 0.926\n",
      "Dose unique values: 279 | zero-dose rows: 0 | negatives: 0\n",
      "BROAD_ID - non-null: 77.84% | uniques: 286\n",
      "ARXSPAN_ID - non-null: 97.55% | uniques: 974\n",
      "DATASET - levels: ['GDSC1', 'GDSC2'] | non-null: 100.00%\n"
     ]
    }
   ],
   "source": [
    "DRUG_PATH = (\"../data/drug-sensitivity.csv\") \n",
    "usecols = [\"DRUG_ID\",\"COSMIC_ID\",\"dose\",\"viability\",\"DATASET\",\"ARXSPAN_ID\",\"DRUG_NAME\",\"BROAD_ID\"]\n",
    "\n",
    "total_rows = 0\n",
    "v_zeros = v_ones = 0\n",
    "v_min, v_max = np.inf, -np.inf\n",
    "viability_vals = []  \n",
    "dose_neg = dose_zero = 0\n",
    "dose_uniques = set()\n",
    "\n",
    "broad_nonnull = broad_null = 0\n",
    "broad_set = set()\n",
    "arx_nonnull = arx_null = 0\n",
    "arx_set = set()\n",
    "dataset_nonnull = dataset_null = 0\n",
    "dataset_set = set()\n",
    "\n",
    "for chunk in pd.read_csv(DRUG_PATH, usecols=usecols, chunksize=300000):\n",
    "    total_rows += len(chunk)\n",
    "\n",
    "    v = pd.to_numeric(chunk[\"viability\"], errors=\"coerce\")\n",
    "    v_zeros += int((v == 0).sum()); v_ones += int((v == 1).sum())\n",
    "    if v.notna().any():\n",
    "        v_min = min(v_min, float(v.min())); v_max = max(v_max, float(v.max()))\n",
    "        viability_vals.append(v.dropna().values)\n",
    "\n",
    "    d = pd.to_numeric(chunk[\"dose\"], errors=\"coerce\")\n",
    "    dose_neg += int((d < 0).sum()); dose_zero += int((d == 0).sum())\n",
    "    dose_uniques |= set(d.dropna().unique())\n",
    "\n",
    "    b = chunk[\"BROAD_ID\"]; bnn = b.notna()\n",
    "    broad_nonnull += int(bnn.sum()); broad_null += int((~bnn).sum())\n",
    "    broad_set |= set(b[bnn].astype(str).unique())\n",
    "\n",
    "    a = chunk[\"ARXSPAN_ID\"]; ann = a.notna()\n",
    "    arx_nonnull += int(ann.sum()); arx_null += int((~ann).sum())\n",
    "    arx_set |= set(a[ann].astype(str).unique())\n",
    "\n",
    "    ds = chunk[\"DATASET\"]; dnn = ds.notna()\n",
    "    dataset_nonnull += int(dnn.sum()); dataset_null += int((~dnn).sum())\n",
    "    dataset_set |= set(ds[dnn].astype(str).unique())\n",
    "\n",
    "v_all = np.concatenate(viability_vals) if viability_vals else np.array([])\n",
    "v_median = float(np.median(v_all)) if v_all.size else float(\"nan\")\n",
    "\n",
    "print(f\"Drug rows: {total_rows:,}\")\n",
    "print(f\"Viability range: [{v_min:.3g}, {v_max:.3g}] | zeros: {v_zeros:,} | ones: {v_ones:,} | median: {v_median:.3f}\")\n",
    "print(f\"Dose unique values: {len(dose_uniques)} | zero-dose rows: {dose_zero:,} | negatives: {dose_neg:,}\")\n",
    "\n",
    "broad_nonnull_pct = 100 * broad_nonnull / total_rows if total_rows else 0\n",
    "arx_nonnull_pct   = 100 * arx_nonnull / total_rows if total_rows else 0\n",
    "dataset_nonnull_pct = 100 * dataset_nonnull / total_rows if total_rows else 0\n",
    "\n",
    "print(f\"BROAD_ID - non-null: {broad_nonnull_pct:.2f}% | uniques: {len(broad_set)}\")\n",
    "print(f\"ARXSPAN_ID - non-null: {arx_nonnull_pct:.2f}% | uniques: {len(arx_set)}\")\n",
    "print(f\"DATASET - levels: {sorted(list(dataset_set))} | non-null: {dataset_nonnull_pct:.2f}%\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8e5e6f43-3212-48c0-87e7-92055c70c490",
   "metadata": {},
   "source": [
    "## 4. Exploratory Data Analysis"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6e18dddd-6749-49dd-ad3d-286d3e3be85b",
   "metadata": {},
   "source": [
    "### 4.1. Tumor Data EDA"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b2089745-ea4c-42b4-9d2b-6fed1eca21b6",
   "metadata": {},
   "source": [
    "#### 4.1.1. Clinical Label Summaries"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fd01ae2c-0316-45d4-ae50-794fd4a64383",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> We will explore the cleaned tumor (mutation) dataset to understand its key characteristics and confirm data quality before moving on to downstream modeling. First, we will summarize the distribution of each clinical label - HER2, ER, PR, vital status, and histology -to ensure our filtering produced the expected sizes. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1271490f-bef9-4e28-9cf6-72807aab1713",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Now I present the categorical distribution in code.<br>\n",
    "The function <code>barplot_counts()</code> takes: </p>\n",
    "<ul>\n",
    "  <li><b>df</b> – input dataframe.</li>\n",
    "  <li><b>column</b> – categorical column to count.</li>\n",
    "  <li><b>title</b> – optional custom title.</li>\n",
    "</ul>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "db174750-d08a-4fae-ba2e-a53e0970ba61",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "e.barplot_counts(mutations_data_clean, \"her2_final_status\", \"HER2 Status Counts\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cf621853-de4e-4254-9c9b-a66d520af768",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> As expected in a breast-cancer dataset, HER2-negative cases far outnumber HER2-positive ones. In our 543‐sample cohort, only about 15% are HER2-positive, while the remaining 85% are HER2-negative. In breast cancer, roughly 15-20% of tumors overexpress HER2. Seeing only 15% of our cohort as HER2-positive means our data mirror the real-world prevalence, so we haven't inadvertently biased the sample. This imbalance is typical and important to keep in mind: downstream comparisons of pathway activity or drug sensitivity will involve far fewer positive samples. </p>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "f90a42ca-7e78-45f2-83ed-13ad8069bfc9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "e.barplot_counts(mutations_data_clean, \"E\", \"ER Status Counts\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ca4c9bd8-a89c-4507-a060-5c2041233f50",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> The bar chart of ER status reveals that the vast majority of our cohort is ER-positive - around $\\frac{3}{4}$ of samples - while ER-negative cases account for roughly $\\frac{1}{4}$. This distribution aligns with clinical patterns, as most breast tumors rely on estrogen signaling. </p>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "56028552-db5d-4b51-9934-62a4ae07e09f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "e.barplot_counts(mutations_data_clean, \"P\", \"PR Status Counts\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "df201a43-2d29-4c03-8d25-0ce0b5e72a3f",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> The PR status bar chart shows that the majority of tumors are PR-positive, indicating active progesterone signaling in most samples. Approximately $\\frac{1}{3}$ of cases are PR-negative, reflecting a substantial subgroup that lacks progesterone receptor expression. This distribution - similar to ER but with a higher proportion of negatives - highlights biological variability in hormone dependence across the cohort. </p>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "f90ff72b-ca9e-4acb-b4da-7524beb810ac",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "e.barplot_counts(mutations_data_clean, \"vital_status\", \"Survival Status Counts\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ae26da6c-c3ff-4573-bcac-b7d78612def1",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> The survival‐status bar chart reveals that the vast majority of patients in our cohort are recorded as alive at last follow-up, with a smaller - but still substantial - fraction marked as deceased. This skew toward \"alive\" is expected in a mix of early- and late-stage samples, but it also highlights that downstream analyses of survival associations may be underpowered for the deceased group alone. </p>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "95431e80-09e1-432b-91e1-6c35826b2320",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "e.barplot_counts(mutations_data_clean, \"histological_type\", \"Histology Counts\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0993aaa3-3104-4242-9572-ba389cbbc0f5",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> The histology bar chart shows that most tumors in our cohort are of the ductal subtype, with a smaller proportion classified as lobular. This anatomical distinction matters because ductal and lobular cancers can differ in their molecular profiles and treatment responses. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "65d9215f-67c4-4c85-a473-c9032af270d1",
   "metadata": {},
   "source": [
    "#### 4.1.2. Distribution of HER2 Signal by HER2 Status"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3a65d704-d131-45bf-a367-089f52930b5b",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> This plot lets us see whether our pp_HER2 measurements align with the clinical HER2 labels. We expect higher median and a right-shifted distribution in the HER2-positive group compared to HER2-negative. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c879304b-4be4-4b35-acbd-5b4a00269957",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Now I present the pathway-by-group comparison in code.<br>\n",
    "The function <code>boxplot_by_group()</code> takes: </p>\n",
    "<ul>\n",
    "  <li><b>df</b> – input dataframe.</li>\n",
    "  <li><b>signal</b> – numeric pathway column (e.g., <code>pp_her2</code>).</li>\n",
    "  <li><b>group</b> – grouping column (e.g., <code>her2_final_status</code>, <code>er_status</code>, <code>pr_status</code>).</li>\n",
    "  <li><b>title</b> – optional custom title.</li>\n",
    "</ul>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "9693bce5-cdfc-4036-967f-5a7b7f7176d5",
   "metadata": {},
   "outputs": [],
   "source": [
    "signal = \"pp_her2\" if \"pp_her2\" in mutations_data_clean.columns else \"pp_her2_py1248\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "cf09a0b3-eeab-4fec-a152-2dc4ca777abb",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAnYAAAHWCAYAAAD6oMSKAAAAOnRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjEwLjEsIGh0dHBzOi8vbWF0cGxvdGxpYi5vcmcvc2/+5QAAAAlwSFlzAAAPYQAAD2EBqD+naQAAO1hJREFUeJzt3QmYjXX/x/HvhBm7LNmyJmUpMdOmXaVSiVZP2aJN0epp8fQv8VQq0V4koiS00J4QKSWMChlFEUWJYmyN7fyvz++5zrnOGbM7M2fOb96v67qZOec+9/mdM/e5z+f+bXdCIBAIGAAAAOLeQbEuAAAAAKKDYAcAAOAJgh0AAIAnCHYAAACeINgBAAB4gmAHAADgCYIdAACAJwh2AAAAniDYAQAAeIJgByDqHnjgAUtISCiS5zrjjDPcEjR79mz33G+++WaRPP/VV19tjRo1sqJW1K8TQHwg2KFEGDt2rPsSDC5ly5a1I444wvr162d//PHHfl+WwaVMmTJ22GGHWY8ePeznn3/O13MqbBx11FFZ3rd69Wq3/ccffzzb5868TJw4MbSugkT4fRUqVLDjjz/eXnnllf2ea/ny5XbXXXdZ69atrVKlSlanTh274IILbOHChQV+7+rWrWvnnnuuPf3007Z161aLhnXr1rlA+O2331pxU5zLVlQhfePGjVner33xwgsvjLgtp/24T58+EaE4/L6kpCT3ubz//vvtn3/+idjmpk2bbOjQoXbaaafZIYccYgcffLCdeOKJNmnSpDy/lj///NNuvfVWa9asmZUrV85q1qzpPjd33323bdu2LbTehAkT7Mknn7SC2rFjh3vf9JkGilrpIn9GIIYGDx5sjRs3dl8aX3zxhb3wwgv24Ycf2tKlS618+fKh9W655RY77rjjbPfu3bZo0SJ78cUX7YMPPrAlS5a4UFOYgs+dWdu2bSN+V1Dr37+/+3n9+vX20ksvWc+ePS0jI8Ouu+660Hq6ffTo0XbppZfaTTfdZFu2bLGRI0e6L8WPP/7Yzj777Hy9d3pPfv/9d/elddttt9nw4cPt3XfftVatWoXW/b//+z+755578h2eBg0a5IKCXlteffLJJ1bYcirbqFGjbN++fYVehnjTvn17d0KUmYJbOIU57aOiffOdd96x//73v/bTTz/Za6+9Flrvq6++snvvvdfOP/98t3+VLl3a3nrrLfvXv/5ly5Ytc3+fnPz111927LHHWnp6uvXu3duFO4XFxYsXu+PAjTfeaBUrVgwFOx0TtH8XNNgFyxNemwwUBYIdSpQOHTq4g7tce+21Vr16dRdM9GVy5ZVXhtY79dRT7bLLLnM/9+rVy30ZKXCNGzfOBgwYUKhlDH/unBx66KHWrVu3iNoP1S4+8cQTEcFOr0u1B8EvLdEXW/Pmzd3teQ124e+d6H349NNPXW3NRRddZGlpaa4WRPSlq6Uw6ctTYTwxMdFiSbW62J8+M+H7Z3a0n4Svp5OPk046yV5//XX32axVq5a7vWXLlrZixQpr2LBhxLrafx999FFXK62a6+zo5GbNmjU2d+5ct/1wCnux3o+AaKEpFiXamWee6f5ftWpVVNaLJTVPqRZCNR3hUlJSIkKdKNAqQCqMHQi9L/fdd5/98ssvNn78+Bz72E2fPt1OOeUU14Sm8hx55JH2n//8x92n2r9gLaWCdLBpTs3A4c3aqamprilOgS742Mx97IL27t3r1qldu7b7wlf4XLt2bcQ6qoFTIM4sfJu5lS2rPnbbt293tan169d3NVJ6rWp2DwQCEetpO+oOMHXqVPf6tK4CjGpS8yq31zlw4EAXPtUMmdn111/v/h6Zmz1jSe+J9hO9V+HdH1RbHB7qgut27tzZ1VLn1lVCn4tSpUq5murMKleu7LoYiP7uqp3XPh38Wwf/vrt27XLNxPpMValSxb3f+hzNmjUropuFPouiWrvgNvSZyGl/zWo/UvcLPZe6UKiMRx99tD311FN5eh9RclFjhxItGIIUdKKxXlZfuln1Tfr777+zfYz6rGX1GD13TgMS9uzZY7/++qtVrVo1T2VTc2qNGjXsQHXv3t0FCzWJhtcUhvv+++9dzZ6aa9WkqwCzcuVKV3siqj3U7frSVNjQl6WE16yo2Uy1hmp6Uw1PsCYnOw899JB7v9R/asOGDa7PlGp31E8uWLOYF3kpWzgFEoUrfdlfc801rul22rRpduedd9pvv/3malTDqUvA22+/7Wqf9AWufotqNlftUl72t9xep/4+Kr/6oilEBimkaOCFnisYanJrysxKds3QCotZ7ccKKLnVjikcSV72Ze3Hktu+rFCoz+Orr77quixkR829ahLWZyn4twqeGKlmT83GqgXXvq7PqmoC1d90/vz57m+tUBds2r344ovtkksucY8N76qQFzoR0vOcddZZrkZSdCKmz4z6CQLZCgAlwMsvv6yqksCMGTMCf/75Z2Dt2rWBiRMnBqpXrx4oV65c4Ndff3XrzZo1y603ZswYt966desCH3zwQaBRo0aBhISEwIIFC/L8nKeffrrbVk7L0KFDQ+sHnzu7Zf369aF1GzZsGDjnnHNcGbUsWbIk0L17d7de3759cy3bnDlz3Ou577778vze5fTaq1SpEmjTpk3o94EDB7rHBD3xxBPud5U1O9q+1tHzZfdejhgxIsv7tGR+Hw899NBAenp66PbJkye725966qmI97Fnz565bjOnsunx2k7Q1KlT3boPPvhgxHqXXXaZe89XrlwZuk3rJSYmRtz23XffudufeeaZbN6p/L/Otm3bBk444YSIx7/99ttuPW0nJ8G/ZU7LBRdcEPGYnNZ9/fXXI967ChUqhPZjvQ+PP/64e5+OOuqowL59+3Is26ZNmwI1a9YMnHrqqYHc/P7774FDDjnElaFZs2aBPn36BCZMmBDYvHnzfuvq9YT/TYP27NkTyMjIiLjt77//DtSqVSvQu3fv0G16LXoevXe57Vvh70X4c956662BypUru+cE8oMaO5QomfuT6SxeHbTVXy2c+qCF01m4+teF9zHLCzWtqHN9ZhqJm13/I9UMBWuFwlWrVi3id9WQBZt8gtRUqJGDOVGtzlVXXeWattQvKRpUo5HT6Fg194n6MqqMBx2U/14gquXTY/NKHfdVAxakfosaEazBMuovWVi0fTX5ZX4ONc2qhuyjjz6KqDnTPtmkSZPQ76rZUa1WXkdh5+V1ah3VIKnmOfhc2u/VVHz66afn6Xk0UEHlyiy7/bhTp04RrzNIzYmZm60z78dqitXnLacaatUUdu3a1TZv3mzPPPNMruVXDe93333nai+nTJliI0aMcItqDzUYQ0tuU/To76ol+Px6bv2v44IGWUWTPjN6b1Rzd95550V12/AbwQ4lynPPPec6davDtg706vuUVcgIhisdxNXEo+a4ggwGUB+crAYnBJuasqIvvrwMaDjhhBPswQcfdM1LGsGnn9XEm1Mzl74o1CSqEKYmwMx97wpKU0Vo6ojsdOnSxTVhacCKRsuqeUlNVAoheQ15Ct/56eDetGnTiN/1pX344Yfn+N5Hg/pmaeR0eNgS7UPB+8M1aNBgv22oCTKn5vr8vk69/xrhqTCnfVtNje+//77dfvvteZ5vUH0bs2ruzK4Zt169ennaj/X49957z/2s5s/HHnvMnXzk1lx+8803u76ImuLnmGOOydNrUOBVM+nzzz/vBmKoiVzNnHpPdJ/2z9wocA4bNsxNI6QR4kE6UYomNc1PnjzZdT/Qvn/OOefYFVdcQchDrhg8gRJFc1bpy0adl/VFm12oCIardu3auZ8Le4RnQehLVmVU/x7VBmnwgjrhZ9e5Wn2qFKY0vYNqzrKbYy+/9GWsoKAwkR19Sc+ZM8dmzJjh+nypDAobmhJDwTQv8tMvLq+yCzV5LVM0BGuAMss80OJAKCgq0AenD1HNoQYc5GXUalG8fu3HWjSAYObMma7f3A033JDtYzQoQeHskUcecftTQf7uOsFTONR+qeNA+NQq2dFnTGVUraf61ilYqkZNg4jyOuVNXvc5nSipn6SmEgr22VTIy6l/ICAEO8ATmnRYzWoPP/ywq5kLpy8dNcfpS1NzdOW1+S0v1BldFDBzoi9P1dRpCgvNO6ZO/5ouJTiiMNpXqlCNTOagpAEb4SMPFXjUnJZZ5lq1/JRNzfua9y5z07RqeIL3F/XrFP39f/zxR1uwYIELMW3atHEjcIsb1ZypJlG1ePPmzcuy1l0jTFUDqQEjB0pTBGk/0FyQuf29FYi1vga7KFBqn1cgzTyqOKf9Ja/7nKiGumPHji7EqhldYVc1lPr7Atkh2AEe0RedRo9m7tenmgmNitQXRHCUXjQomGkyWTVDqb9TfkZUBif6Vc2RBOcgy+pLryD0BRgervSlrC9v1XoEqeZF4UG1mUFqosw8LUp+yqYJdFX78uyzz0bcrhGW+sIPf/6iep2i31XLq6bHzz77rFjU1mVH+6umtFGNXDjtw+o3qH1NJwj58fXXX+93wiMazarPjLplhP+9VQudXe1qeG2qtqvJk8MFJzvPan/RPqeQHz79jPr+BUeIB6lMmU+MgiNrg58ZICvFr30JKOE+//zzLOcV00E9tykT9OWtJlZ96fXt29fNX6bpLxTodOUKfeGEzzcnmpIhp4ldg9TpX19ImlZFgz8U6tQMpRooNRflNGWGOqyryUu1ilpffahUJvXDUkf54BeeOoyrQ7v6p6lM6kdY0L5LGmyibWvAhcqr90HNxeFTsqhPlYKQ+i2p/5JqRfT+hA9myG/ZVMOiJnxNm6F+bur/pYEuav5WLVPmbR+ovLxO0b6gqWIUOBVQwifkLgyqHcy8r4n6tqoJPiea5kWvR/uIpvhQtwkFMNU66j7V/GZuOtX0M6pNy6lmWY/R/q654VQbpm2PGTPG7bvBeRFF9ytE3nHHHW4OQ/VF1d9VzdmqrdM2tC9rXkvtEy1atIi4JJm6Deg2bUNNvvob6XOpRQOz9PlUbZ+mw9FnQdtQ7ammUwnfN3VCpGZefU5Uo6dBIjohCvbXBLKUrzG0QJzKy5Qd4VNIvPHGGwf8nJrSoGXLllnet2rVqnxPdxI+dYKmRcg8xUTQ2LFjI6bm0DQKOW1XZcnLexdcND1H7dq1A+3bt3dTaoRPtZHddCczZ84MdOrUKVC3bl33eP1/5ZVXBn788ceIx73zzjuBFi1aBEqXLh3xGnJ6L7Ob7kTTagwYMMBNh6EpbfR+/fLLL/s9ftiwYW7KkKSkpMDJJ58cWLhwYZZTUmRXtszTVMjWrVsDt99+u3udZcqUCTRt2tT9rTNP35Hd9DTZTcMSLr+vU+bPn+8eo6ly8ir4t8xuqpqs9sWc9rfw9zU43UlWfvrpp0CpUqVC70Pm/TDzktVUNOEWL14cuPPOOwPJycmBatWqub9jnTp1Apdffnlg0aJFEetu27YtcNVVVwUOPvhgt+3g31d/v4cfftj9rv1FU/y8//77We4DX375ZSAlJcXt75k/v+PHjw8cdthh7r7WrVsHpk2btt823nzzTfd30t9V6zVo0CBwww03REx7BGQlQf9kHfkAAD5Rk59qfNR8W5BBBwCKP/rYAUAJob6XalaMZj9LAMULfeyAfFKn55ymw1DfncyTCQOxpBGmGon84osvukmD89KnEkB8oikWyCdNI5HV1ARBmkpEF44HitM+q4EV6rCvQQSZJ08G4A+CHZBPmpZg586dOc5TpVF1AAAUNYIdAACAJxg8AQAA4IkSNXhCl1XSpX7UvyTaly8CAAAoDGpc1RVm6tatm+01zktksFOoq1+/fqyLAQAAkG+63KGuRJKTEhXsgiPB9MZUrlw51sUBAADIlS43p4qpvIxoL1HBLtj8qlBHsAMAAPEkL93IGDwBAADgCYIdAACAJwh2AAAAniDYAQAAeIJgBwAA4AmCHQAAgCcIdgAAAJ4g2AEAAHiCYAcAAOAJgh0AAIAnCHYAAACeINgBAAB4gmAHAADgidKxLgAAAD7YsWOHLV++PE/r7ty501avXm2NGjWycuXK5bp+s2bNrHz58lEoJXxHsAMAIAoU6lJSUgpl26mpqZacnFwo24ZfCHYAAESBatUUwPIiLS3NunXrZuPHj7fmzZvnadtAXhDsAACIAjWV5rdWTaGOmjhEE4MnAAAAPEGwAwAA8ATBDgAAwBNxG+weeeQRS0hIsNtuuy3WRQEAACgW4jLYLViwwEaOHGmtWrWKdVEAAACKjbgLdtu2bbOuXbvaqFGjrGrVqrEuDgAAQLERd8Gub9++dsEFF9jZZ5+d67oZGRmWnp4esQAAAPgqruaxmzhxoi1atMg1xebFkCFDbNCgQYVeLgAAgOIgbmrs1q5da7feequ99tprVrZs2Tw9ZsCAAbZly5bQom0AAAD4Km5q7HSZlg0bNkTM0L13716bM2eOPfvss67ZtVSpUhGPSUpKcgsAAEBJEDfB7qyzzrIlS5ZE3NarVy93/by77757v1AHAABQ0sRNsKtUqZIdddRREbdVqFDBqlevvt/tAAAAJVHc9LEDAACAJzV2WZk9e3asiwAAAFBsUGMHAADgCYIdAACAJwh2AAAAniDYAQAAeIJgBwAA4AmCHQAAgCcIdgAAAJ4g2AEAAHiCYAcAAOAJgh0AAIAnCHYAAACeINgBAAB4gmAHAADgCYIdAACAJwh2AAAAniDYAQAAeIJgBwAA4AmCHQAAgCcIdgAAAJ4g2AEAAHiCYAcAAOAJgh0AAIAnCHYAAACeINgBAAB4gmAHAADgCYIdAACAJwh2AAAAniDYAQAAeIJgBwAA4AmCHQAAgCcIdgAAAJ4g2AEAAHiCYAcAAOAJgh0AAIAnCHYAAACeINgBAAB4gmAHAADgCYIdAACAJwh2AAAAniDYAQAAeIJgBwAA4AmCHQAAgCcIdgAAAJ4g2AEAAHiCYAcAAOAJgh0AAIAnCHYAAACeINgBAAB4gmAHAADgibgKdi+88IK1atXKKleu7Ja2bdvaRx99FOtiAQAAFAtxFezq1atnjzzyiKWmptrChQvtzDPPtE6dOtn3338f66IBAADEXGmLIx07doz4/aGHHnK1ePPmzbOWLVvGrFwAAADFQVwFu3B79+61N954w7Zv3+6aZLOSkZHhlqD09PQiLCEAAEDRiqumWFmyZIlVrFjRkpKSrE+fPjZlyhRr0aJFlusOGTLEqlSpElrq169f5OUFAAAoKnEX7I488kj79ttv7euvv7Ybb7zRevbsacuWLcty3QEDBtiWLVtCy9q1a4u8vAAAAEUl7ppiExMT7fDDD3c/p6Sk2IIFC+ypp56ykSNH7reuavW0AAAAlARxV2OX2b59+yL60QEAAJRUcVVjp6bVDh06WIMGDWzr1q02YcIEmz17tk2bNi3WRQMAeGzNmjW2cePGqG0vLS0t4v9oqVGjhvuORMkVV8Fuw4YN1qNHD1u/fr0bDKHJihXq2rdvH+uiAQA8DnVHNmtu/+zcEfVtd+vWLarbK1uuvP2wPI1wV4LFVbAbPXp0rIsAAChhVFOnUFf9wv5Wpnp0ZlcI7Nlle7b8YaWr1LKE0olR2ebuTWtt0/vDXHkJdiVXXAU7AABiRaEuqfb/Bu9FRb2sp+oCSvTgCQAAAPwPwQ4AAMATBDsAAABPEOwAAAA8QbADAADwBMEOAADAEwQ7AAAATxDsAAAAPEGwAwAA8ATBDgAAwBMEOwAAAE8Q7AAAADxBsAMAAPAEwQ4AAMATBDsAAABPEOwAAAA8QbADAADwBMEOAADAEwQ7AAAATxDsAAAAPEGwAwAA8ATBDgAAwBMEOwAAAE8Q7AAAADxBsAMAAPAEwQ4AAMATBDsAAABPEOwAAAA8QbADAADwBMEOAADAEwQ7AAAATxDsAAAAPEGwAwAA8ATBDgAAwBMEOwAAAE8Q7AAAADxBsAMAAPAEwQ4AAMATBDsAAABPEOwAAAA8QbADAADwBMEOAADAEwQ7AAAATxDsAAAAPEGwAwAA8ATBDgAAwBMEOwAAAE8Q7AAAADwRN8FuyJAhdtxxx1mlSpWsZs2a1rlzZ/vhhx9iXSwAAIBiI26C3WeffWZ9+/a1efPm2fTp02337t12zjnn2Pbt22NdNAAAgGKhtMWJjz/+OOL3sWPHupq71NRUO+2002JWLgAAgOIibmrsMtuyZYv7v1q1arEuCgAAQLEQNzV24fbt22e33XabnXzyyXbUUUdlu15GRoZbgtLT04uohAAAAEUvLmvs1Ndu6dKlNnHixFwHXFSpUiW01K9fv8jKCAAAUNTiLtj169fP3n//fZs1a5bVq1cvx3UHDBjgmmyDy9q1a4usnAAAAEUtbppiA4GA3XzzzTZlyhSbPXu2NW7cONfHJCUluQUAAKAkKB1Pza8TJkywd955x81l9/vvv7vb1cRarly5WBcPAAAg5uKmKfaFF15wzalnnHGG1alTJ7RMmjQp1kUDAAAoFuKqKRYAAAAeBDsAAGKldsUEOzpxnZVJKGXF1e7EdWYVE2JdDMQYwQ4AgFzckJJoD9QdYcVaXbMHUhJjXQrEGMEOAIBcjEzdZV8ecauVqV5850PdvWmtLUkdahfFuiCIKYIdAAC5+H1bwGxXXUsK5D7VVqxk7Nr7v3KiRIubUbEAAADIGcEOAACgJAe7ffv2ZXv7mjVrDrRMAAAAKOxgl56ebldccYVVqFDBatWqZffff7/t3bs3dP+ff/6Zp0t9AQAAIMaDJ+677z777rvv7NVXX7XNmzfbgw8+aIsWLbK3337bEhP/N8SaiYQBAADioMZu6tSpNnLkSLvsssvs2muvtYULF7pauo4dO1pGRoZbJyGByREBAACKfbBTiGvYsGHo9xo1atiMGTNs69atdv7559uOHTsKo4wAAACIdrBr0KCBpaWlRdxWqVIl++STT2znzp128cUX52dzAAAAiFWwO+ecc+zll1/e7/aKFSvatGnTrGzZstEsGwAAAApr8MSgQYNs3bp1Wd6nmrvp06e7wRQAAAAo5jV2VatWtSOOOMLOOussW7FiRZbh7vTTT49m+QAAAFBYExSXKVPGFi9enN+HAQAAoDheeaJbt242evTo6JcGAAAARdPHLmjPnj02ZswYN9VJSkqKuxJFuOHDhxe8RAAAACi6YLd06VJLTk52P//4448R9zFBMQAAQBwFu1mzZkW/JAAAACj6PnZBK1eudPPXaXJi4TqxAAAAcRbsNm3a5KY80dQnupTY+vXr3e3XXHON9e/fP9plBAAAQGEFu9tvv91Ne7JmzRorX7586PYuXbrYxx9/XJBNAgAAIBZ97HRtWDXB1qtXL+L2pk2b2i+//HKgZQIAAEBR1dht3749oqYu6K+//rKkpKSCbBIAAACxCHannnqqvfLKKxFTnOzbt88ee+wxa9eu3YGWCQAAAEXVFKsAp8ETCxcutF27dtldd91l33//vauxmzt3bkE2CQAAgFjU2B111FFuYuJTTjnFOnXq5JpmL7nkEvvmm2+sSZMmB1omAAAAFFWNnVSpUsXuvffegj4cAAAAxSXYbd682ebPn28bNmxw/evC9ejRIxplAwAAQGEHu/fee8+6du1q27Zts8qVK0dcH1Y/E+wAAADipI+dri7Ru3dvF+xUc/f333+HFg2gAAAAQJwEu99++81uueWWLOeyAwAAQBwFu3PPPddNdQIAAIA47GP37rvvhn6+4IIL7M4777Rly5bZ0Ucf7a4bG+6iiy6KbikBAAAQvWDXuXPn/W4bPHjwfrdp8MTevXvzulkAAAAUdbDLPKUJAAAAPOhjl1dqpl27dm1hPgUAAACKItitXr3adu/eXZhPAQAAgKIIdgAAACg6BDsAAABPEOwAAAA8QbADAADwBMEOAADAE4Ua7EaOHGm1atUqzKcAAADAgQa7mTNn2oUXXmhNmjRxi36eMWNGxDpXXXWVVahQoaBPAQAAgMIOds8//7ydd955VqlSJbv11lvdUrlyZTv//PPtueeeK8gmAQAAUFSXFAv38MMP2xNPPGH9+vUL3XbLLbfYySef7O7r27fvgZYLAAAARVFjt3nzZldjl9k555xjW7ZsKcgmAQAAEItgd9FFF9mUKVP2u/2dd95xfe0AAAAQJ02xLVq0sIceeshmz55tbdu2dbfNmzfP5s6da/3797enn346ook2WubMmWNDhw611NRUW79+vQuXnTt3jtr2AQAASlywGz16tFWtWtWWLVvmlqCDDz7Y3ReUkJAQ1WC3fft2O+aYY6x37952ySWXRG27AAAAJTbYrVq1KvRzIBAIhbjC1qFDB7cABbVjxw5bvnx5ntbduXOnrV692ho1amTlypXLdf1mzZpZ+fLlo1BKAACKMNiJauY0MnbFihXu96ZNm9ptt91m1157rRUXGRkZbglKT0+PaXkQewp1KSkphbJtdRFITk4ulG0DAFBowe7++++34cOH28033xzqY/fVV1/Z7bffbmvWrLHBgwdbcTBkyBAbNGhQrIuBYkS1agpgeZGWlmbdunWz8ePHW/PmzfO0bQAA4i7YvfDCCzZq1Ci78sorI0bKtmrVyoW94hLsBgwYYHfccUdEjV39+vVjWibElppK81urplBHTRwAwNtgt3v3bjv22GP3u11NXHv27LHiIikpyS0AAAAlQYHmsevevburtcvsxRdftK5du0ajXAAAACjKwROffPKJnXjiie73r7/+2vWv69GjR0Tzp/riRcu2bdts5cqVEaNzv/32W6tWrZo1aNAgas8DAABQYoLd0qVLQ32OfvrpJ/d/jRo13KL7gqI9BcrChQutXbt2od+DAbJnz542duzYqD4XAABAiQh2s2bNslg444wzQvPmAQAAIAp97AAAAFD8EOwAAAA8QbADAADwBMEOAADAEwQ7AAAATxDsAAAAPEGwAwAA8ATBDgAAwBMEOwAAAE8Q7AAAADxBsAMAAPAEwQ4AAMATBDsAAABPEOwAAAA8QbADAADwBMEOAADAEwQ7AAAATxDsAAAAPEGwAwAA8ATBDgAAwBMEOwAAAE8Q7AAAADxBsAMAAPAEwQ4AAMATBDsAAABPEOwAAAA8QbADAADwBMEOAADAEwQ7AAAATxDsAAAAPEGwAwAA8ATBDgAAwBMEOwAAAE8Q7AAAADxBsAMAAPAEwQ4AAMATpWNdAAAA4sHuTWujtq3Anl22Z8sfVrpKLUsonVjsyof4RbADACAHNWrUsLLlytum94dZcadyqrwouQh2AADkoEGDBvbD8jTbuHFj1LaZlpZm3bp1s/Hjx1vz5s2jtl2FOpUXJRfBDgCAXCgsFUZgUqhLTk6O+nZRcjF4AgAAwBMEOwAAAE8Q7AAAADxBHzt4Y82aNVHv3Bz+f7TQuRkAUFgIdvAm1B3ZrLn9s3NH1LetkWvRno5AI+wIdwCAaCPYwQuqqVOoq35hfytTvX6xnkBUc2GpvAQ7AEC0EezgFYW6pNqHR2+D9VpEb1sAABQyBk8AAAB4gmAHAADgibgLds8995w1atTIypYtayeccILNnz8/1kUCAAAoFuIq2E2aNMnuuOMOGzhwoC1atMiOOeYYO/fcc23Dhg2xLhoAAEDMxVWwGz58uF133XXWq1cva9GihY0YMcLKly9vY8aMiXXRAAAAYi5ugt2uXbssNTXVzj777NBtBx10kPv9q6++yvIxGRkZlp6eHrEAAAD4Km6Cneb92rt3r9WqVSvidv3++++/Z/mYIUOGWJUqVUJL/frRmd8MAACgOIqbYFcQAwYMsC1btoSWtWvXxrpIAAAAhSZuJijW9TVLlSplf/zxR8Tt+r127dpZPiYpKcktAAAAJUHc1NglJiZaSkqKzZw5M3Tbvn373O9t27aNadkAAACKg7ipsRNNddKzZ0879thj7fjjj7cnn3zStm/f7kbJAgAAlHRxFey6dOlif/75p91///1uwETr1q3t448/3m9ABQAAQEkUV8FO+vXr5xYAAADEaR87AAAA5IxgBwAA4Im4a4oFslO7YoIdnbjOyiSUsuJqd+I6s4oJsS4GAMBTBDt444aURHug7ggr1uqaPZCSGOtSAAA8RbCDN0am7rIvj7jVylQvvpeO271prS1JHWoXxbogAAAvEezgjd+3Bcx21bWkQGMrrjJ27f1fOQEAKAQMngAAAPAEwQ4AAMATBDsAAABPEOwAAAA8QbADAADwBMEOAADAEwQ7AAAATxDsAAAAPEGwAwAA8ATBDgAAwBMEOwAAAE8Q7AAAADxBsAMAAPAEwQ4AAMATBDsAAABPlI51AYBo2r1pbdS2Fdizy/Zs+cNKV6llCaUTi135AADIjGAHL9SoUcPKlitvm94fZsWdyqnyAgAQbQQ7eKFBgwb2w/I027hxY9S2mZaWZt26dbPx48db8+bNo7ZdhTqVFwCAaCPYwRsKS4URmBTqkpOTo75dAACijcETAAAAniDYAQAAeIJgBwAA4AmCHQAAgCcIdgAAAJ4g2AEAAHiCYAcAAOAJgh0AAIAnCHYAAACeINgBAAB4gmAHAADgCYIdAACAJwh2AAAAniDYAQAAeIJgBwAA4AmCHQAAgCcIdgAAAJ4g2AEAAHiCYAcAAOAJgh0AAIAnCHYAAACeINgBAAB4gmAHAADgCYIdAACAJ0pbnHjooYfsgw8+sG+//dYSExNt8+bNsS4SAAAhO3bssOXLl+dp3bS0tIj/c9OsWTMrX778AZUPJUPcBLtdu3bZ5Zdfbm3btrXRo0fHujgAAERQqEtJScnXY7p165an9VJTUy05ObmAJUNJEjfBbtCgQe7/sWPHxrooAABkWaumAJYXO3futNWrV1ujRo2sXLlyedo24FWwAwCgOFNTaX5q1U4++eRCLQ9KJq+DXUZGhluC0tPTY1oeAAAAb0fF3nPPPZaQkJDjkteOqFkZMmSIValSJbTUr18/quUHAAAoTmJaY9e/f3+7+uqrc1znsMMOK/D2BwwYYHfccUdEjR3hDgAA+Cqmwe6QQw5xS2FJSkpyCwAAQEkQN33s1qxZY3/99Zf7f+/evW4+Ozn88MOtYsWKsS4eAABAzMVNsLv//vtt3Lhxod/btGnj/p81a5adccYZMSwZAABA8RA3lxTT/HWBQGC/hVAHAAAQZ8EOAAAAOSPYAQAAeIJgBwAA4AmCHQAAgCcIdgAAAJ4g2AEAAHiCYAcAAOAJgh0AAIAnCHYAAACeINgBAAB4gmAHAADgCYIdAACAJwh2AAAAniDYAQAAeIJgBwAA4AmCHQAAgCdKx7oAQFHasWOHLV++PE/rpqWlRfyfm2bNmln58uUPqHwAABwIgh1KFIW6lJSUfD2mW7dueVovNTXVkpOTC1gyAAAOHMEOJYpq1RTA8mLnzp22evVqa9SokZUrVy5P2wYAIJYSAoFAwEqI9PR0q1Klim3ZssUqV64c6+IAAABENb8weAIAAMATBDsAAABPEOwAAAA8QbADAADwBMEOAADAEwQ7AAAATxDsAAAAPEGwAwAA8ATBDgAAwBMEOwAAAE8Q7AAAADxBsAMAAPBEaStBAoFA6GK6AAAA8SCYW4I5JiclKtht3brV/V+/fv1YFwUAACDfOaZKlSo5rpMQyEv888S+ffts3bp1VqlSJUtISIh1cRAHZ0g6CVi7dq1Vrlw51sUB4BGOL8gPRTWFurp169pBB+Xci65E1djpzahXr16si4E4o4MuB14AhYHjC/Iqt5q6IAZPAAAAeIJgBwAA4AmCHZCNpKQkGzhwoPsfAKKJ4wsKS4kaPAEAAOAzauwAAAA8QbADAADwBMEOAADAEwQ7IEoaNWpkTz75ZKyLAaAYmz17tpsgf/PmzTmux/EEBUWwQ1y4+uqr3cHwkUceibh96tSpRX4VkbFjx9rBBx+83+0LFiyw66+/vkjLAqBwjzlaEhMT7fDDD7fBgwfbnj17Dmi7J510kq1fvz402SzHE0QbwQ5xo2zZsvboo4/a33//bcXRIYccYuXLl491MQBEyXnnnedC2IoVK6x///72wAMP2NChQw9omwqJtWvXzvWElOMJCopgh7hx9tlnuwPikCFDsl3niy++sFNPPdXKlSvnrsN4yy232Pbt20P36yB9wQUXuPsbN25sEyZM2K/JY/jw4Xb00UdbhQoV3DZuuukm27ZtW6gZpVevXrZly5bQ2bwO9hK+nauuusq6dOkSUbbdu3dbjRo17JVXXgldu1ivReVQeY455hh78803o/yuASgozTGnY07Dhg3txhtvdMegd999151c9ujRw6pWrerCV4cOHVz4C/rll1+sY8eO7n4dR1q2bGkffvjhfk2xHE9QGAh2iBulSpWyhx9+2J555hn79ddf97v/p59+cmfYl156qS1evNgmTZrkgl6/fv1C6+hgvG7dOndAfeutt+zFF1+0DRs27HdN4aefftq+//57GzdunH366ad21113hZpRdLDVtR0VErX8+9//3q8sXbt2tffeey8UCGXatGm2Y8cOu/jii93vOgjroDxixAj3XLfffrt169bNPvvss6i+bwCiQ4Fp165drpl24cKFLuR99dVX7gLt559/vgtb0rdvX8vIyLA5c+bYkiVLXEtDxYoV99sexxMUCk1QDBR3PXv2DHTq1Mn9fOKJJwZ69+7tfp4yZYom2HY/X3PNNYHrr78+4nGff/554KCDDgrs3LkzkJaW5tZdsGBB6P4VK1a425544olsn/uNN94IVK9ePfT7yy+/HKhSpcp+6zVs2DC0nd27dwdq1KgReOWVV0L3X3nllYEuXbq4n//5559A+fLlA19++WXENvQatB6A4nPM2bdvX2D69OmBpKSkQOfOnd0xY+7cuaF1N27cGChXrlxg8uTJ7vejjz468MADD2S53VmzZrnH//333+53jieIttKFExeBwqOz3zPPPHO/M9vvvvvO1dS99tprodt0Jq0milWrVtmPP/5opUuXtuTk5ND96hCt5pJwM2bMcGe/y5cvt/T0dNdZ+p9//nFnx3nt86LnueKKK1xZunfv7pqD33nnHZs4caK7f+XKlW577du3j3icagPatGlToPcFQHS9//77rqZNNXE6jqhJ9JJLLnG3n3DCCaH1qlevbkceeaSlpaW539UFRE23n3zyiWu+VStCq1atClwOjifID4Id4s5pp51m5557rg0YMMA1iQSpmeKGG25wB9XMGjRo4IJdblavXm0XXnihOyg/9NBDVq1aNdece80117iDZH46M6v55PTTT3dNvdOnT3fNOGoqDpZVPvjgAzv00EMjHse1I4HioV27dvbCCy+4AQ9169Z1AUvNr7m59tpr3TFKn2+FO50oDhs2zG6++eYCl4XjCfKKYIe4pGlPWrdu7c6Sg1QTt2zZMlcLlxWtq9q3b775xlJSUkJnuuGjbFNTU92ZuQ7C6msnkydPjtiODvJ79+7NtYzqP6PBF+rr99FHH9nll19uZcqUcfe1aNHCHXDXrFnjDtYAih8NfMh8PGnevLk7jnz99dfuMy6bNm2yH374wX2ug/TZ79Onj1t0Ejpq1Kgsgx3HE0QbwQ5xSaNWdQarQQ5Bd999t5144olusITOmHVQVtDT2e2zzz5rzZo1c80imhtKZ+E6KGoKA535Bqce0EFczS4aoKFRbXPnznWdkcNptJrOkGfOnOlGnqkWL7uaPDXd6PGqLZw1a1bo9kqVKrmmZHVwVpA85ZRT3Mg4PZ86Uvfs2bPQ3jsABde0aVPr1KmTXXfddTZy5Ej3Wb7nnntcTZlul9tuu82NlD3iiCPciaM++wqEWeF4gqiLeq89oJA7MgetWrUqkJiYGBo8IfPnzw+0b98+ULFixUCFChUCrVq1Cjz00EOh+9etWxfo0KGD6wStzskTJkwI1KxZMzBixIjQOsOHDw/UqVPHdYY+99xzXYfl8M7O0qdPHzegQrcPHDhwv87OQcuWLXPr6D51wA6n35988snAkUceGShTpkzgkEMOcc/32WefRfGdAxCtY07QX3/9Fejevbsb9BA8Tvz444+h+/v16xdo0qSJO87oc611NcAiq8ETwvEE0ZSgf6IfF4H4oGlT1LyhARNnnXVWrIsDAMABIdihRNGcdGr2UFOu5ozS/HS//faba9oI9lcBACBe0ccOJYr6z/3nP/+xn3/+2fVLUYdkTSFAqAMA+IAaOwAAAE9wSTEAAABPEOwAAAA8QbBD3NFkoDVr1nRXiYhnmvvqQGaiB1A04uGYozk769Wr5y43hpKNYIe4o0t9aSJQTexZ2DRrvCYvfvLJJ0O36eCuS4w1btzYTW7cpEkTGzhwoLvkWPg6elzmZd68eaF1NKHouHHj3EAOACX3mKOR+ppYXcFMxxRdSSJ8YvS//vrLnQTq6jm6X5dI1KUTNQlxkB6jCdqHDx9eKGVE/GBULOKKLnQ9evRomzZtWqE/15QpU1wQ0zUiwy1fvtzN7q5Z53WliqVLl7pZ6HWm/Pjjj0esq/nxWrZsGXGx8KAaNWq460nqKhhDhw4t9NcDoHgec+644w43FdP48eNdeNT1ZW+66SZ37Lnooots3bp1btHxRQHul19+cSeduu3NN98MbadXr17uWKRLmOm6tiihojrdMVDI3njjDTejelBwFvcZM2YEUlJS3Czwbdu2DSxfvvyAnufXX38NHHrooYGlS5dmOQN8Zo899ligcePGEVfFULm++eabHB83bty4QL169Q6orADi+5jTsmXLwODBgyNuS05ODtx7773ZPmby5Mnuyju7d+8O3ZaRkeGudqGyoeSiKRZx5fPPP7eUlJT9br/33ntt2LBhtnDhQnem2rt374jHVKxYMcdFc9kFqTaue/fuduedd0bUtuVETSLVqlXb73adbatvjq7d+O677+53//HHH++uflGc++4AJVlRHHM0n6aOD5osXTOQ6TqwmjT9nHPOyfGYo+vAhtfMJSYmWuvWrd3zo+SirhZxRU0QmZtGg31gTj/99NCghAsuuMD++ecfK1u2rB177LH27bff5rjdWrVqhX5+9NFH3cFSfVjyYuXKlfbMM89ENMPqwK2D/sknn2wHHXSQvfXWW9a5c2ebOnWqC3tBwdei11UUfQYBFL9jjo4f119/vetjp2OPjhmjRo2y0047LcvHbty40f773/+6x2SmsqrMKLkIdogrO3fudAfOzFq1ahX6uU6dOu7/DRs2uE7G6mysvnB5kZqaak899ZQtWrTIDXbIjc6wzzvvPLv88std35bw/nPqNxN03HHHuf4w6ksXHuxUtmA/HgAl75gTDHbqz6tau4YNG9qcOXOsb9++LqSdffbZEeump6e7EKm+dg888MB+29Jzczwp2WiKRVxRYPr777/3uz38kmDBQKYm1fw2i2jd4MFZZ85adPbbv3///WrUFNTatWvnmlFefPHFXMt+wgknuNq9cBrtJoccckiB3g8A8X3MUXDUZQ41mrVjx44uMGqEbJcuXfYbjLV161Z3IqnLIWpwV1aXQtQxheNJyUaNHeJKmzZt3Mix/MhPs4j61mU+Q9bIVd2uEWfhNXUKdep78/LLL7umk9yoDMEz+yCNqNXBOa99+QD4dczR9au1ZD6GlCpVKhQUgzV1OhYlJSW5mr2sahGDx5TLLrssX+WFXwh2iCs6sGkov86gq1atmqfH5KdZRNORhE9JIgpetWvXdnNIBUPdGWec4ZpMdEb9559/htbVeqL56dSRWV8K8vbbb9uYMWPspZdeiti2zuxPPfXUUJMsgJJ1zNEACPXV02AtPU7Hlc8++8xeeeWV0Jx0CnUaSKEmVoVM/a5FVDunECgahKXjU+aTU5QsBDvElaOPPtqSk5Nt8uTJdsMNN8SkDNOnT3dNqlrU2TmcRrQFqXOzmnHVnNusWTObNGnSfmfSEydOzLKfDICSc8zRcUDhsWvXrq4pVeFOgzM0V52oz+/XX3/tfs4cGFetWhXqJvL666+7AKjHo+RK0JwnsS4EkB8ffPCBO7tVk0NemkCLq48++sj13Vu8eDGTiQLFWDwcc3Tlm6ZNm9qECRPcaHyUXHybIO5oRNiKFStck0P9+vUtXulKFeqfR6gDird4OOasWbPGDcIg1IEaOwAAAE8UzzplAAAA5BvBDgAAwBMEOwAAAE8Q7AAAADxBsAMAAPAEwQ5AodOVOm677TYrbn7//Xdr3769VahQwQ4++ODQdT+nTp1aIl4/AP8Q7ADErSFDhthxxx3nLopes2ZN69y5s/3www95fvwTTzxh69evd9f1/PHHH91t+r1Dhw5WHBU0IF599dXuvQHgP4IdgLijWfZF19Ts27evzZs3z13qTRdT1yWVNPlzXvz000+WkpLiZuxXMAxe71cXWgeAeESwA1Ak9u3bZ3fddZdVq1bNhafwa+Ru3rzZrr32WndBc10U/cwzz7TvvvsudL/Wbd26tb300kvWuHFjK1u2rLv9448/drVRLVu2tGOOOcbGjh3rZuBPTU3NtTy6vuZbb73lLrau5ldtJ3NTrC6qrt/ffvtta9eunZUvX949z1dffRXazqZNm+zKK6+0Qw891N2va4vqmp0F9fzzz7ugqddYq1at0PWFVT4F2aeeesqVSYvKt3fvXrvmmmvc+6KLyB955JFunfD3bty4cfbOO++EHjd79my36Ge990GquQxuV3St444dO1rVqlVdc7Xe5w8//LDArw1A4eNaRgCKhMLFHXfc4S5mrmCkoKLLH6mP2+WXX+5Cia6fW6VKFRs5cqSdddZZrnlUQVBWrlzpgphCVqlSpbJ8ji1btrj/g4/JyYIFC6xHjx4uSCoI6fmzc++999rjjz/uApd+VpBTeXQ5uH/++cfV+t19991uW7quaPfu3a1JkyZ2/PHH5+s9Wrhwod1yyy326quv2kknneQuCP/555+7+1RGvR9HHXWUDR482N2mIKzAXK9ePXvjjTesevXq9uWXX9r1119vderUsSuuuML+/e9/W1pamqWnp7tL2AXfH62XG9WGqnZ0zpw5LtgtW7bMKlasmK/XBKBoEewAFIlWrVrZwIED3c8KSM8++6zNnDnTBar58+fbhg0bQk2gClGqNXvzzTddSBEFDNWuKcxkRQFH/c8UFhV+cqPt6Pn0/KpBzInCka4XKoMGDXI1Vwp2zZo1czV1uj/o5ptvtmnTptnkyZPzHexU26gAdeGFF7p+gw0bNrQ2bdq4+xR4ExMTXa1geHkVclWmINXcKTjr+RXsFMT0GjMyMnJ9nVmV59JLL3W1kHLYYYfl6/EAih7BDkCRBbtwqlFSmFOT67Zt21xtU7idO3e6PnBBCjnZhbpg7dLSpUvtiy++KNSyq9yisivYqSn04YcfdkFKF4lXAFWIUgDLL9Ve6nUqQJ133nluufjii3Pd1nPPPWdjxoxxQUzvm8qgpusDpdrDG2+80T755BM7++yzXcjL/HcEULzQxw5AkShTpkzE7+rLpVo2hTqFJfXvCl80uvXOO+8Mra+arOz069fP3n//fZs1a5ZrlizMsqvcorLL0KFDXTOpmmL1/Cr7ueeeGxrgkR+qpVu0aJHro6f35P7773d9+sL7wWU2ceJEV2OofnYKYHr+Xr165fr8Bx30v8N/IBAI3abBJ+HU7/Hnn392TctLliyxY4891p555pl8vy4ARYcaOwAxlZyc7OaTU381DWjID4USNX1OmTLFDQZQM2RRmzt3rnXq1Mm6desWCnzqC9eiRYsCbU/vg2rHtKjpWvPrffrpp3bJJZe4pljVEGZ+fvXHu+mmm0K3hdd0SlaPC9Z+anoXDY4QhcLM6tevb3369HHLgAEDbNSoUe49B1A8UWMHIKYUYNq2bevmWVONk0ZkqmO/BiloMEFO1Pw6fvx4mzBhgqvtUkDUoubIoqL+gppqRWXWIIUbbrjB/vjjjwJtS7WOTz/9tAtYGpGqPoUKihrpKgq+Gnyi92jjxo3uPj2/3if161OgvO+++9zAkHB63OLFi10tqB6nmrnDDz/chTaNml2xYoUb9DFs2LCIx6nPora7atUqV5OoGsnmzZsfwLsFoLAR7ADElJo2NYXGaaed5poQjzjiCPvXv/7lgo2m+8jJCy+84EbCauJeNV0Gl0mTJhVZ+f/v//7P1Tqq+VXl0ACFgk4GrNo5jfrVdC8KUCNGjHDNshqsIWpy1WAJ1Qaqxk196hQkVZvXpUsXO+GEE9z0K+G1d3Lddde5cKimVD1OtXxqXta2ly9f7vrNPfroo/bggw9GPE61fArPKov6++lvo+lYABRfCYHwDhYAAACIW9TYAQAAeIJgB8BLr732mpvDLasl2LRZ1DTZcHZlYuJfANFAUywAL23dujXbQQzqX6b54oqaBnVorrvsaEADABwIgh0AAIAnaIoFAADwBMEOAADAEwQ7AAAATxDsAAAAPEGwAwAA8ATBDgAAwBMEOwAAAE8Q7AAAAMwP/w9jQw4bImZUrwAAAABJRU5ErkJggg==",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "e.boxplot_by_group(\n",
    "    mutations_data_clean,\n",
    "    signal,\n",
    "    \"her2_final_status\",\n",
    "    f\"{signal.upper()} Distribution by HER2 Status\"\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5e919c0f-cbfb-4495-ae99-901509544b52",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> The boxplot shows that HER2-negative samples form a compact, low-value cluster, with a tight interquartile range near the bottom of the pp_HER2 scale. In contrast, HER2-positive samples have a markedly higher median phosphorylation level and a broader spread, reflecting greater variability in pathway activation among positives. Together, these patterns confirm that our pp_HER2 signal reliably tracks clinical HER2 status. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3d385933-604e-46ad-8ba8-c70e0842160f",
   "metadata": {},
   "source": [
    "#### 4.1.3. Histogram & Density of HER2 Signal"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5656ef64-ae2b-4044-86b5-ac538335ee77",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Now I present the signal distribution in code.<br>\n",
    "The function <code>hist_density()</code> takes: </p>\n",
    "<ul>\n",
    "  <li><b>df</b> – input dataframe.</li>\n",
    "  <li><b>column</b> – numeric column to plot.</li>\n",
    "  <li><b>bins</b> – number of histogram bins (default 40).</li>\n",
    "</ul>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "9dbf34ce-b855-417d-80c5-178ecea272e5",
   "metadata": {},
   "outputs": [],
   "source": [
    "signal = \"pp_her2\" if \"pp_her2\" in mutations_data_clean.columns else \"pp_her2_py1248\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "c955fd89-7611-4a82-8ef4-5a9176103b8e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "e.hist_density(mutations_data_clean, signal)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ee6c9090-ccbf-464f-a251-e9868169cc0b",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> The histogram and density plot of the pp_HER2 signal reveal a clear right‐skew: most tumors cluster at low to moderate phosphorylation levels, with a tail of samples showing much higher activation. There’s a single dominant peak around the lower values, suggesting the bulk of the cohort has modest HER2 pathway activity, while the few high‐end outliers may represent exceptionally driven tumors. This skew tells us that a simple linear model might struggle to capture those extremes. The overall spread confirms substantial variability across the cohort. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8089cb4f-e125-4284-ac7d-4d8dde524d03",
   "metadata": {},
   "source": [
    "#### 4.1.4. Signal by Hormone‐Receptor Status"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "703473f0-2a69-4f01-8fa6-5f424a9dd6a8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Boxplots of pp_HER2 by ER status\n",
    "if \"E\" in mutations_data_clean.columns:\n",
    "    e.boxplot_by_group(\n",
    "        mutations_data_clean,\n",
    "        signal,\n",
    "        \"E\",\n",
    "        f\"{signal.upper()} by ER Status\"\n",
    "    )\n",
    "\n",
    "# Boxplots of pp_HER2 by PR status\n",
    "if \"P\" in mutations_data_clean.columns:\n",
    "    e.boxplot_by_group(\n",
    "        mutations_data_clean,\n",
    "        signal,\n",
    "        \"P\",\n",
    "        f\"{signal.upper()} by PR Status\"\n",
    "    )"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0c8878e7-c17a-461a-97f0-18fd0c845e24",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> The data show that ER-positive tumors actually have slightly higher HER2 phosphorylation than ER-negative ones. Likewise, PR-positive samples exceed PR-negative cases. These findings imply that hormone-receptor positivity is associated with modestly greater HER2 pathway activation, rather than a compensatory increase in the receptor-negative groups. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "559123be-b02b-434a-9d96-62d25ac26e8f",
   "metadata": {},
   "source": [
    "#### 4.1.5. Cross-Tables for Final Status and Hormone-Receptor"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "0a52285f-4717-4713-9155-0310113684b5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>er_status</th>\n",
       "      <th>Negative</th>\n",
       "      <th>Positive</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>her2_final_status</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Negative</th>\n",
       "      <td>98</td>\n",
       "      <td>327</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Positive</th>\n",
       "      <td>26</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "er_status          Negative  Positive\n",
       "her2_final_status                    \n",
       "Negative                 98       327\n",
       "Positive                 26        56"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>er_status</th>\n",
       "      <th>Negative</th>\n",
       "      <th>Positive</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>her2_final_status</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Negative</th>\n",
       "      <td>0.231</td>\n",
       "      <td>0.769</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Positive</th>\n",
       "      <td>0.317</td>\n",
       "      <td>0.683</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "er_status          Negative  Positive\n",
       "her2_final_status                    \n",
       "Negative              0.231     0.769\n",
       "Positive              0.317     0.683"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "ct_er = pd.crosstab(mutations_data_clean[\"her2_final_status\"], mutations_data_clean[\"er_status\"])\n",
    "ct_er_pct = pd.crosstab(mutations_data_clean[\"her2_final_status\"], mutations_data_clean[\"er_status\"], normalize=\"index\").round(3)\n",
    "display(ct_er); \n",
    "display(ct_er_pct)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6e8b1bb9-333d-4f2d-ba6b-2994d5eb6eec",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Reading the table row-wise (conditioning on HER2 status), the distribution of ER labels within each HER2 group indicates that HER2-positive tumors are relatively enriched for ER-negative disease and depleted for ER-positive compared with HER2-negative tumors. This pattern is consistent with the known tendency for a subset of HER2-amplified cancers to lack hormone-receptor signaling. Interpretation should primarily rely on the row percentages (composition within each HER2 stratum) while using the counts to gauge stability - cells with very small counts warrant caution. Entries marked \"Unknown/Indeterminate/Not performed\" were not treated as negatives and were excluded from these subgroup summaries to avoid misclassification. </p>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "2126f71b-51a0-4b71-a8cc-f90dcfef9d6c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>pr_status</th>\n",
       "      <th>Negative</th>\n",
       "      <th>Positive</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>her2_final_status</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Negative</th>\n",
       "      <td>138</td>\n",
       "      <td>287</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Positive</th>\n",
       "      <td>38</td>\n",
       "      <td>44</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "pr_status          Negative  Positive\n",
       "her2_final_status                    \n",
       "Negative                138       287\n",
       "Positive                 38        44"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>pr_status</th>\n",
       "      <th>Negative</th>\n",
       "      <th>Positive</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>her2_final_status</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Negative</th>\n",
       "      <td>0.325</td>\n",
       "      <td>0.675</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Positive</th>\n",
       "      <td>0.463</td>\n",
       "      <td>0.537</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "pr_status          Negative  Positive\n",
       "her2_final_status                    \n",
       "Negative              0.325     0.675\n",
       "Positive              0.463     0.537"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "ct_pr = pd.crosstab(mutations_data_clean[\"her2_final_status\"], mutations_data_clean[\"pr_status\"])\n",
    "ct_pr_pct = pd.crosstab(mutations_data_clean[\"her2_final_status\"], mutations_data_clean[\"pr_status\"], normalize=\"index\").round(3)\n",
    "display(ct_pr); \n",
    "display(ct_pr_pct)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8db9f8c6-bf1d-4cdc-a242-dfa9ee890948",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Within the HER2-negative group, PR- = 138 and PR+ = 287 (n=425), yielding 32.5% PR- / 67.5% PR+. Within the HER2-positive group, PR- = 38 and PR+ = 44 (n=82), yielding 46.3% PR− / 53.7% PR+. Thus, PR positivity is lower in HER2-positive tumors (53.7%) than in HER2-negative (67.5%), with a corresponding rise in PR negativity (32.5% -> 46.3%). Descriptively, the crude odds of being PR-positive are 0.56x in HER2-positive vs HER2-negative (44x138 vs 38x287). Given the smaller HER2-positive stratum (n=82), we note the potential for wider uncertainty; formal inference is presented later, but the table already suggests a shift toward PR negativity in the HER2-positive subset. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "22230182-0862-4459-a2e7-283355c5ae0b",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Taken together, the receptor cross-tabs show that HER2-positive tumors skew away from hormone-receptor positivity. In the PR table, HER2- cases are 67.5% PR+ / 32.5% PR- (287/138; n=425) whereas HER2+ cases are 53.7% PR+ / 46.3% PR− (44/38; n=82), indicating a clear shift toward PR negativity in the HER2+ stratum. The ER table points in the same direction (a higher proportion of ER− within HER2+ than within HER2−). While some HER2+ cells are smaller and should be interpreted cautiously, the row-normalized percentages are consistent: when HER2 is positive, hormone-receptor positivity (ER/PR) is less common. We'll carry this pattern forward in the narrative and avoid collapsing HER2 with ER/PR groups without justification. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "22b0e646-8668-4e1f-80d0-d669fc51466e",
   "metadata": {},
   "source": [
    "### 4.2. Drug Sensitivity EDA"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "02092740-f524-42e6-adf1-3020fde3baab",
   "metadata": {},
   "source": [
    "#### 4.2.1. Top Drugs by Measurement Count"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bfee8ff4-81b5-48a7-9d07-a4bf5470d170",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Now I present the most-measured drugs in code.<br>\n",
    "The function <code>bar_top_drugs_by_count()</code> takes: </p>\n",
    "<ul>\n",
    "  <li><b>drug_df</b> – cleaned drug dataframe.</li>\n",
    "  <li><b>top_n</b> – how many drugs to display (default 20).</li>\n",
    "</ul>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "d7e84757-7347-4579-b330-9671f6dfd151",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "e.bar_top_drugs_by_count(drug_data_clean, 20)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4a2f6b2d-8ab1-4e98-8271-908c34a8d40b",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> The bar chart reveals that afatinib, linsitinib, and PLX-4720 top the list in measurement count - each with hundreds of data points - making them prime candidates for robust dose-response modeling. Afatinib (an irreversible EGFR/HER2 inhibitor) and linsitinib (an IGF-1R inhibitor) provide valuable data on targeted kinase pathways, while PLX-4720 (a BRAF inhibitor) serves as a useful comparator outside the HER2 axis. The presence of both pathway-specific inhibitors and off-target agents in this top tier sets up a strong analytical framework for distinguishing on-target versus background effects. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "23e90a3e-d052-4c13-8b35-5fd81d198e86",
   "metadata": {},
   "source": [
    "#### 4.2.2. Dose-Viability Plots"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5b43a2e9-17a7-40dc-a68c-28e43d3601e3",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Now I present median dose-response curves in code.<br>\n",
    "The function <code>median_response_logdose()</code> takes: </p>\n",
    "<ul>\n",
    "  <li><b>df</b> – cleaned drug dataframe with <code>drug_name</code>, <code>dose</code>, <code>viability</code>.</li>\n",
    "  <li><b>drugs</b> – list of drug names (strings) to plot.</li>\n",
    "</ul>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "9db93b42-282a-4964-b33c-50b22c4fae5b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "top = (\n",
    "    drug_data_clean[\"drug_name\"]\n",
    "    .value_counts()\n",
    "    .rename_axis(\"drug\")\n",
    "    .reset_index(name=\"count\")\n",
    ")\n",
    "\n",
    "top5_names = top[\"drug\"].astype(str).tolist()[:5]\n",
    "e.median_response_logdose(drug_data_clean, top5_names)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "aa12736b-3765-40c9-90bc-51b1b61787e1",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Drugs whose curves begin to decline at lower $\\log_{10}$(dose) values achieve half‐maximal viability reduction at smaller concentrations, indicating higher potency. For each compound, the lowest point reached by its curve represents the median minimal viability, so a curve dipping further downward demonstrates greater overall efficacy. The slope of each curve - the range of log‐doses over which median viability falls - reflects how uniformly cell lines respond: a steep descent over a narrow dose window means most lines behave similarly, whereas a gradual decline indicates diverse sensitivities. Comparing curves directly shows that HER2‐targeted inhibitors require lower concentrations to suppress viability and drive the median response closer to zero than off‐target agents like PLX‐4720, highlighting their stronger and more specific activity. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9f9dcc4f-ec56-4722-b288-58a9b0b7fa77",
   "metadata": {},
   "source": [
    "#### 4.2.3. ECDF of Viability for Top Drugs"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "dbc82ce8-e41f-4b24-9c5d-2c7f59703a06",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Now I present ECDF comparisons in code.<br>\n",
    "The function <code>plot_ecdf()</code> takes: </p>\n",
    "<ul>\n",
    "  <li><b>df</b> – cleaned drug dataframe.</li>\n",
    "  <li><b>drug_names</b> – list of drug names to include.</li>\n",
    "</ul>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "806f84e4-1689-481d-a139-0151e07b3aa9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "top3_names = top[\"drug\"].astype(str).tolist()[:3]\n",
    "e.plot_ecdf(drug_data_clean, top3_names)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7033480a-d160-4fe6-9c90-4b9d59640c83",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> For the top three drugs, the ECDF curves make their relative potencies immediately clear. Afatinib's ECDF climbs most slowly, indicating that it drives viability below 50% in roughly half of all measurements - demonstrating its superior ability to suppress cell growth across the panel. Linsitinib's curve is steeper than afatinib's but still notably delayed compared to PLX-4720, reflecting moderate but consistent activity. In contrast, PLX-4720's ECDF rises almost vertically at high viability values, showing that the vast majority of its measurements remain above 80-90% viability; this confirms that PLX-4720 has minimal impact on most breast-cancer lines in our dataset. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bce6d303-d0c1-414f-afbb-02b2889a496e",
   "metadata": {},
   "source": [
    "#### 4.2.4. Violin Plot of Viability Distributions"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "40e5ebab-98a6-4695-8a78-179b00dab939",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Now I present viability distribution shapes in code.<br>\n",
    "The function <code>violin_viability()</code> takes: </p>\n",
    "<ul>\n",
    "  <li><b>df</b> – cleaned drug dataframe.</li>\n",
    "  <li><b>drugs</b> – list of drug names to include.</li>\n",
    "</ul>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "c16de17c-b4b3-4d08-9796-570d2ed11490",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "e.violin_viability(drug_data_clean, top3_names)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "63d6b812-686e-4063-a028-5233b963635c",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> For all three drugs, the bulk of measurements cluster at high viability values - each violin plot is widest near 80-100%, indicating that most cell-dose combinations yield minimal killing. Afatinib's violin, however, shows a longer lower tail extending toward 20-40% viability, revealing a subset of cell lines that are notably sensitive to this inhibitor. Linsitinib's distribution has a moderate lower tail, more pronounced than PLX-4720 but less than afatinib, peaking broadly around 60-80% viability. In contrast, PLX-4720's violin is sharply peaked at the top end with almost no lower tail, confirming that it produces virtually no strong responses in our panel. These shapes illustrate that while resistance predominates for all compounds, afatinib has the largest fraction of sensitive outcomes, linsitinib shows intermediate sensitivity, and PLX-4720 shows almost none. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4d4add53-61cc-49e9-89f2-45a7f1f778b0",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> We've now completed a full exploratory profile on both sides of our study. In the tumor cohort, we confirmed that clinical HER2, ER, and PR labels match the underlying phospho-HER2 measurements and that hormone-receptor context subtly shapes pathway activity. On the drug side, we identified our most data-rich compounds, traced their median dose-response curves on a $\\log_{10}$ scale, compared full viability distributions via ECDFs, and used violin plots to capture response heterogeneity. Together, these eight figures show, with clear mathematical grounding, that HER2 pathway activation is a real and measurable signal both in patient tumors and in vitro drug responses. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fafa968a-2e05-4754-b905-cc3c75bea14f",
   "metadata": {},
   "source": [
    "## 5. Statistical Testing & Interpretation"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ce5934be-a2b6-4434-8811-1175ae0a663c",
   "metadata": {},
   "source": [
    "### 5.1. Hypotheses"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "30b74fc3-c284-4501-8608-7c404a3a457a",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> We test three related claims about HER2 biology and drug response using the cleaned datasets.\n",
    "\n",
    "$H_1$ (Survival vs Pathway): Vital status is associated with HER2 pathway activity (median-split into High vs Low). Null: no association.\n",
    "\n",
    "$H_2$ (Drug Potency vs Targeting): HER2-targeted agents yield lower viability than non-targeted comparators. Null: no difference in viability distributions.\n",
    "\n",
    "$H_3$ (HER2 Status vs Pathway): Tumors labeled HER2-positive exhibit higher HER2 pathway activity than HER2-negative. Null: equal distributions. \n",
    "\n",
    "</p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fbf9a414-bfd4-4b90-9dcf-0826bad21543",
   "metadata": {},
   "source": [
    "### 5.2. Association of HER2 Pathway Activity with Vital Status"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "12c0e118-de24-4708-bbe6-ae18644a1400",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> To assess whether elevated HER2 pathway activity predicts patient mortality, we split the data at the median pp_HER2 signal into \"High\" and \"Low\" groups. We then construct a 2x2 table of HER2‐High vs. HER2‐Low against vital status (deceased vs. alive) and apply a chi‐square test of independence. An odds ratio quantifies how much more likely a deceased outcome is in the High‐signal group. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2e5e83aa-9a62-4c30-93c3-ea6330b6cc5c",
   "metadata": {},
   "source": [
    "#### 5.2.1. Hypotheses"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "802f9cee-83b0-4067-add5-f56e6cb45b14",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> \n",
    "Hypothesis ($H_1$): Patients' vital status differs by pathway group: tumors with High HER2 pathway activity have a different (worse) survival profile than those with Low activity. Null Hypothesis ($H_0$): Vital status and pathway group are independent (no association). Direction: We expect the High-activity group to be enriched for deaths relative to Low.\n",
    "Goal: Test whether vital status (0=alive, 1=deceased) is associated with HER2 pathway activity.</p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d3188381-f35b-44f0-a8bb-d3bcd8a30d92",
   "metadata": {},
   "source": [
    "#### 5.2.2. Chosen metrics and tests"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e2adc809-af00-4a6d-af7a-fae8461af03a",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> A) Median Split </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7bfed898-ffc3-42d7-8111-8b67c801e1ca",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> We median-split the continuous pathway signal pp_her2 to form \n",
    "$ \\text{her2\\_group} \\in \\set{High,Low} $. This creates balanced groups without searching for an \"optimal\" threshold (which would inflate Type-I error) and yields a simple 2x2 contingency table for independence tests and an interpretable odds ratio for death in High vs Low. It is:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "45f1f5f2-a117-4123-b41f-8dc903089468",
   "metadata": {},
   "source": [
    "| HER2 Group | Alive (0) | Deceased (1) | Total |\n",
    "|---|---:|---:|---:|\n",
    "| High | 231 | 23 | 254 |\n",
    "| Low  | 214 | 39 | 253 |\n",
    "| **Total** | 445 | 62 | 507 |"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c5653f75-9a53-44c9-9b8a-161841ba010e",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> B) Chi-square test (2x2) </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "dc887af5-2fb3-4be8-9ba6-de1a3e8e96b3",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> The chi-square test checks whether two categorical variables are independent in the population. Here, we ask: Is vital status distributed the same way in the High vs Low `pp_her2` groups? If the distribution differs beyond what random sampling would plausibly produce, we call it \"associated\". </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5dc09945-c544-4f0a-981a-4b2e3a71ecfc",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Expected counts - if group and outcome were truly unrelated, the proportion of deaths would be the same in both groups. Mathematically, the expected count in a cell is: </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8d281f54-dd32-4c83-9165-6455226430c6",
   "metadata": {},
   "source": [
    "$$  E_{ij}=\\frac{(\\text{row total}_i)\\,(\\text{column total}_j)}{N} = $$ \n",
    "$$  E_{ij}=\\frac{(\\mathrm{row}_i)(\\mathrm{col}_j)}{N}$$"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0d3bf698-aed2-4a3c-9196-ccdbb62085f2",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> These $E_{ij}$ are the yardsticks we compare to the observed counts $O_{ij}$. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2cf31d9d-8a2a-460a-9694-57026be210b0",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Statistic (no continuity correction) - the chi-square statistic adds up, over all 4 cells, how far observed counts deviate from expected counts after scaling by expected counts: </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e70dca21-dfd4-4dac-ab75-2c99e1499be5",
   "metadata": {},
   "source": [
    "$$\\chi^2=\\sum_{i=1}^{2}\\sum_{j=1}^{2}\\frac{(O_{ij}-E_{ij})^2}{E_{ij}}$$"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "49cb3639-8835-47b0-9c20-f094180d2a07",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Yates correction for 2x2 - cecause counts are discrete, a small adjustment can make the test slightly more conservative in 2x2 tables - useful when counts are modest: </p>\n",
    "$$\n",
    "\\chi^2_Y=\\sum_{i=1}^{2}\\sum_{j=1}^{2}\\frac{(|O_{ij}-E_{ij}|-\\tfrac{1}{2})^2}{E_{ij}} =\n",
    "\\sum\\frac{\\big(|O_{ij}-E_{ij}|-\\tfrac{1}{2}\\big)^2}{E_{ij}}\n",
    "$$"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "404a7dec-ca68-45fc-a8c0-41bf07d33efe",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> C) Fisher's exact test (2x2) </p>  "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b9c76030-c55c-4562-9f35-81bd4bcd34af",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Fisher's test answers the same independence question but does not rely on large-sample approximations. It computes the exact probability of seeing our table (or any table more \"extreme\") under the null hypothesis of independence. With row and column totals treated as fixed, the count in one cell (say, $a$) follows a hypergeometric distribution. The two-sided p-value sums the probabilities of all tables that are at least as unlikely (as \"extreme\") as the observed one. Because it is exact, Fisher’s test is dependable even with small cell counts:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5a7c34e2-0e16-496e-b078-f6d86381d2b6",
   "metadata": {},
   "source": [
    "Two-sided exact $p$-value:\n",
    "$$p=\\frac{\\binom{a+b}{a}\\binom{c+d}{c}}{\\binom{N}{a+c}},$$\n",
    "will be applied to a=23; b=231; c=39; d=214"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b038b7ff-df8e-441b-a0aa-44572eb7ce81",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> D) Odds ratio (High vs Low odds of death) </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "db5f4756-23c6-4e63-af2c-164e2e2512c4",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> The odds ratio (OR) compares the odds of death in the High group to the odds in the Low group: </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0767b965-eafc-44c2-b07d-3e5e6fbeafad",
   "metadata": {},
   "source": [
    "$$\n",
    "\\mathrm{OR}=\\frac{a\\,d}{b\\,c}\n",
    "$$\n",
    "Wald 95% CI on the log scale:\n",
    "$$\n",
    "\\log(\\mathrm{OR})\\pm 1.96\\sqrt{\\tfrac{1}{a}+\\tfrac{1}{b}+\\tfrac{1}{c}+\\tfrac{1}{d}}\n",
    "\\;\n",
    "$$"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "cda89cba-e7f6-47fd-9e50-f0e72c593ee9",
   "metadata": {},
   "source": [
    "$ \\mathrm{OR}=1: \\text{no difference in odds} $\n",
    "$ \\mathrm{OR}<1: \\text{death is less likely in High than in Low (here, roughly half the odds)}$\n",
    "$ \\mathrm{OR}>1: \\text{death is more likely in High} $\n",
    "\n",
    "**Why log-scale.** Sampling variation is more symmetric on the **log-OR**, so we build the interval for $\\log(\\mathrm{OR})$ and then exponentiate back. Exponentiating the endpoints gives a 95% CI for OR. If the entire CI is **below 1**, the data are consistent with **lower odds** of death in the High group."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "517a378f-12fe-4658-8f04-49eb2b017332",
   "metadata": {},
   "source": [
    "#### 5.2.3. Tests Performance"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2dfcd0f5-5deb-4833-8065-f86aba38e28f",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Now I present the HER2 grouping step and survival association tests in code.<br>\n",
    "The function <code>add_her2_group_by_median()</code> takes: </p>\n",
    "<ul>\n",
    "  <li><b>df</b> – cleaned tumor dataframe.</li>\n",
    "  <li><b>signal_col</b> – pathway signal column (e.g., <code>pp_her2</code>).</li>\n",
    "</ul>\n",
    "<p style=\"font-size:18px;\"> The function <code>survival_chi2_fisher()</code> takes: </p>\n",
    "<ul>\n",
    "  <li><b>df_with_group</b> – dataframe containing <code>her2_group</code> and <code>vital_status</code> (0=alive, 1=deceased).</li>\n",
    "</ul>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "a4f3d6b2-f5aa-494f-ba08-3459da906cbb",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'chi2_p': 0.040367831674562774,\n",
       " 'fisher_p': 0.030625597215985928,\n",
       " 'odds_ratio': 0.5463425463425463,\n",
       " 'table': Deceased      0   1\n",
       " HER2 Group         \n",
       " High        231  23\n",
       " Low         214  39}"
      ]
     },
     "execution_count": 44,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Evaluate result\n",
    "signal_col = \"pp_her2\"\n",
    "mutations_with_group, median_val = s.add_her2_group_by_median(mutations_data_clean, signal_col)\n",
    "res_surv = s.survival_chi2_fisher(mutations_with_group)\n",
    "\n",
    "res_surv"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "52879589-6152-4827-98b8-07f4f7f9dcbf",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> The chi‐square test yielded a p‐value of 0.04, indicating a statistically significant association between HER2 pathway activity and mortality. Fisher's exact test corroborates this finding (p = 0.031). The odds ratio of 0.54 shows that patients in the High pp_HER2 group have only half the odds of being deceased compared to those in the Low group. In other words, elevated HER2 phosphorylation is associated with better survival in this cohort. This surprising result suggests that higher pathway activity may correlate with more responsive tumor biology, or it could reflect treatment effects in HER2‐positive patients receiving targeted therapies. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a31abc30-8570-49f7-bb8b-d99c605638f9",
   "metadata": {},
   "source": [
    "### 5.3. Association of Drug Potency with Targeting Status"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "adb1ba7c-0183-44b8-af31-5cf3a5f516f9",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> We now test the second arm of our hypothesis - that HER2‐targeted inhibitors produce stronger reductions in viability than non‐targeted comparators. We will compare the distributions of viability across all doses for two groups of drugs (targeted vs. comparator) using the Mann-Whitney U test, and we'll also report the mean fraction of measurements below 50% viability in each group. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9fd67d93-6d66-4ffc-a91e-cccbaf5f5169",
   "metadata": {},
   "source": [
    "#### 5.3.1. Hypotheses"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d4f6b34a-5cf3-4a7d-b6ad-bd6e96101c9f",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Hypothesis ($H_2$): HER2-targeted drugs produce lower cell viability than non-targeted comparators, indicating greater potency against HER2-driven contexts.\n",
    "Null Hypothesis ($H_0$): The viability distributions for targeted and comparator drugs are the same.\n",
    "Direction: One-sided expectation: targeted < comparator in viability. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d51223b7-0309-4e64-8c0d-a66911d670e3",
   "metadata": {},
   "source": [
    "#### 5.3.2. Chosen metrics and tests"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bb5ff422-8fe7-491d-b02c-4ccd6a6180fb",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> A) Fraction below 50% viability (per drug) </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7bd71a7e-d0c8-4512-99ae-90c28d5bead8",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> For each drug, we take all its viability measurements (across doses) and count what share is below a threshold (by default 50%). If a drug's fraction is 1.00, it means all recorded measurements were < 50% (very potent across the tested doses). If it is 0.00, none were < 50%. If it's NA, there wasn't any data for that drug after cleaning. This is an easy, descriptive potency summary. It's not the inferential test, because many drugs (including comparators) can also cross 50% at some dose, the fraction can \"saturate\" at 1.00. That's why we also compare the full distributions with a rank test."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2d68d8c7-0f31-4549-833b-eae2a0bff915",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> B) Mann-Whitney Test </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4793184c-77a5-488b-a306-f55a3aede2dc",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> This test asks: Does one group tend to give different values than the other? Here, we ask whether targeted drugs produce lower viabilities than comparators. Instead of comparing means (like the independent samples t-test), the Mann-Whitney U test compares the ranks of all observations:\n",
    "\n",
    "1) We put the two samples together and rank all values (lowest to highest).  \n",
    "2) We then add up the rank sums for each group.  \n",
    "3) If one group systematically has lower values, its rank sum will be smaller -> the test statistic $U$ reflects that difference.  \n",
    "4) The p-value tells us how likely we'd see a rank difference this large if, in truth, the two groups came from the same distribution."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1820a6e4-af79-49b2-b8d1-0847db2ae952",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\">We have two independent groups: targeted viabilities $X_1,\\dots,X_{n_x}$ and comparator viabilities $Y_1,\\dots,Y_{n_y}$. Lower viability means stronger drug effect.</p> \n",
    "\n",
    "<p style=\"font-size:18px;\">Step 1 - rank everything together. Pool all $N=n_x+n_y$ values and rank them from smallest to largest (use average ranks for ties). Let $R_i$ be the pooled rank of $X_i$.</p> \n",
    "\n",
    "<p style=\"font-size:18px;\">Step 2 - compute a rank sum and $U$. The targeted rank sum is $R_X=\\sum_{i=1}^{n_x} R_i$. Convert it to the U-statistic with $U_X = R_X - \\dfrac{n_x(n_x+1)}{2}.$ (You can also get the other group’s value by $U_Y = n_x n_y - U_X$.)</p> \n",
    "\n",
    "<p style=\"font-size:18px;\">Step 3 - standardize to a Z-score (quick large-sample version, no tie correction): $\\mathbb{E}[U_X]=\\dfrac{n_x n_y}{2},\\quad \\mathrm{SD}(U_X)=\\sqrt{\\dfrac{n_x n_y (n_x+n_y+1)}{12}},\\quad Z=\\dfrac{U_X-\\mathbb{E}[U_X]}{\\mathrm{SD}(U_X)}.$</p> \n",
    "\n",
    "<p style=\"font-size:18px;\">Step 4 - pick the tail that matches our claim. Here we expect targeted to be smaller than comparator, so targeted should get smaller ranks and a smaller $U_X$. Use the one-sided p-value $p=\\Phi(Z)$ (smaller, more negative $Z$ gives a smaller $p$). For a two-sided check, use $p = 2\\min\\{\\Phi(Z),\\,1-\\Phi(Z)\\}.$</p> "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a0eeafbd-2284-4cd7-a901-21a9865b7c6c",
   "metadata": {},
   "source": [
    "#### 5.3.3. Tests Performance"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "acd52b21-2e1c-4f04-9803-f342b513064c",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Now I present fraction-below-threshold comparisons and targeted vs comparator testing in code.<br>\n",
    "The function <code>frac_below()</code> takes: </p>\n",
    "<ul>\n",
    "  <li><b>df</b> – cleaned drug dataframe.</li>\n",
    "  <li><b>drugs</b> – list of drug names to evaluate.</li>\n",
    "  <li><b>thresh</b> – viability cutoff (default 50%).</li>\n",
    "</ul>\n",
    "<p style=\"font-size:18px;\">The function <code>mannwhitney_targeted_vs_comparators()</code> takes: </p>\n",
    "<ul>\n",
    "  <li><b>df</b> – cleaned drug dataframe.</li>\n",
    "  <li><b>targeted</b> – list of HER2-targeted drugs.</li>\n",
    "  <li><b>comparators</b> – list of non-targeted controls.</li>\n",
    "  <li><b>alternative</b> – 'two-sided' | 'less' | 'greater' (default 'two-sided').</li>\n",
    "</ul>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "4761b00f-2791-4ccb-9041-e02d50ea3b95",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "({'afatinib': 1.0, 'lapatinib': 1.0, 'tucatinib': nan},\n",
       " {'plx-4720': 1.0, 'doxorubicin': 1.0, 'paclitaxel': 1.0},\n",
       " {'u_stat': 1399211548.0,\n",
       "  'p_value': 1.9042841595584433e-209,\n",
       "  'n_targeted': 57986,\n",
       "  'n_comp': 53945})"
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "targeted = [\"afatinib\", \"lapatinib\", \"tucatinib\"]\n",
    "comparators = [\"plx-4720\", \"doxorubicin\", \"paclitaxel\"]\n",
    "\n",
    "targ_frac = s.frac_below(drug_data_clean, targeted, thresh=50)\n",
    "comp_frac = s.frac_below(drug_data_clean, comparators, thresh=50)\n",
    "res_u = s.mannwhitney_targeted_vs_comparators(drug_data_clean, targeted, comparators, \"less\")\n",
    "targ_frac, comp_frac, res_u"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7a8c3a8b-1f7d-4f2f-987c-5e38eaad04b6",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> The fraction‐sensitivity metric shows that afatinib and lapatinib each achieved 100% of measurements below 50% viability, while tucatinib lacked sufficient data to compute this metric. Interestingly, our comparator drugs (PLX-4720, doxorubicin, and paclitaxel) also each showed 100% of measurements under the 50% threshold - indicating that at least one dose for each compound drove median viability below this cutoff. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9a3b4173-505d-4043-b8d3-d17591c6a513",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Despite these uniform fractions, the Mann-Whitney U test comparing the full viability distributions of the targeted versus comparator groups yields a p-value of $1.90 \\times 10^{-209}$, demonstrating an extremely significant difference between the two sets of curves. This result confirms that the overall viability profiles for HER2-targeted inhibitors differ markedly from those of non-targeted agents, supporting our hypothesis that targeted drugs reduce cancer cell viability more potently than general chemotherapies. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d5f69374-b024-44f0-8e07-2957eb674dad",
   "metadata": {},
   "source": [
    "### 5.4. Association of HER2 Status with HER2 Pathway Activity"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "019ad96c-e961-4e49-83b4-d7f30aa580a3",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> To formally test whether HER2-positive tumors exhibit higher HER2 pathway activation, we compare pp_HER2 levels between HER2-positive and HER2-negative cases in the mutations_data_clean dataset using the Mann-Whitney U test (non-parametric, one-sided alternative = \"greater\").</p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f1abb0c7-40d1-4a85-87cc-c3b5d0f0fda0",
   "metadata": {},
   "source": [
    "#### 5.4.1. Hypotheses"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d5da0d5c-20a2-43ef-8dc6-7fd486eee7f2",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Hypothesis ($H_3$): HER2-positive tumors show higher HER2 pathway activity (pp_HER2) than HER2-negative tumors, reflecting biological concordance between label and signaling.\n",
    "Null Hypothesis ($H_0$): The pathway activity distributions are equal between HER2-positive and HER2-negative groups.\n",
    "Direction: One-sided expectation: HER2+ > HER2− in pathway activity. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "36be3862-19d3-4db8-b50d-1c20e750692f",
   "metadata": {},
   "source": [
    "#### 5.4.2. Chosen metrics and tests"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "35fc741a-89ce-40b9-a593-18f316c730ab",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\">We use the Mann-Whitney U test to compare ppHER2 between HER2+ and HER2- tumors (one-sided, HER2+ > HER2−). The test reports $U$ and a p-value based on pooled ranks; we also show group medians for context.</p> "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6daa3019-d954-4332-9021-9e1d09aac807",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\">We compare HER2+ to HER2− tumors on ppHER2 using a one-sided Mann–Whitney U test (HER2+ > HER2−). The method uses ranks (not means), needs only independent groups with ordinal data, and yields $U$ and a p-value; larger HER2+ ranks indicate higher pathway activity.</p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9f805a73-d2e3-4222-af80-2af3ef32caf5",
   "metadata": {},
   "source": [
    "#### 5.4.3. Tests Performance"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ba3de6a6-5828-4798-8f42-f88136e9ba59",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Now I present HER2 status vs pathway testing in code.<br>\n",
    "The function <code>mwu_status_vs_signal()</code> takes: </p>\n",
    "<ul>\n",
    "  <li><b>df</b> – cleaned tumor dataframe.</li>\n",
    "  <li><b>signal_col</b> – pathway signal column (e.g., <code>pp_her2</code>).</li>\n",
    "  <li><b>alternative</b> – 'greater' | 'less' | 'two-sided' (default 'greater' tests HER2+ > HER2−).</li>\n",
    "</ul>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "c8837431-31b8-47af-9f01-1a0141e79e90",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'u_stat': 29627.0,\n",
       " 'p_value': 4.809019626801056e-24,\n",
       " 'median_pos': 1.880747558125,\n",
       " 'median_neg': -0.1542867435}"
      ]
     },
     "execution_count": 46,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "res_status = s.mwu_status_vs_signal(mutations_data_clean, signal_col, alternative=\"greater\")\n",
    "res_status"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "520603af-5b08-4a1d-8632-5aa9a524cdba",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> The test yielded a U statistic of 29627 with a p-value of $4.81 \\times 10^{-24}$, providing extremely strong evidence that HER2-positive tumors have higher HER2 pathway activity than HER2-negative tumors. The median pp_HER2 signal for HER2-positive cases is substantially greater than for HER2-negative cases. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6d926f54-ead6-4c8d-bd29-a5b5010c9813",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> This result directly confirms the first part of our hypothesis - that HER2 status corresponds to elevated pathway activation - and complements our earlier exploratory visualizations with a robust statistical validation. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e1577aac-3300-4210-86e2-d98ea36830b1",
   "metadata": {},
   "source": [
    "## 6. Narrative Synthesis"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2514c579-336c-45e4-9034-4f17e477dfb8",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> In this project, we hypothesized that HER2-positive tumors exhibit elevated HER2 pathway activity, and that HER2-targeted drugs reduce cancer cell viability more effectively than non-targeted agents. To explore this, we analyzed two complementary datasets: molecular profiles of breast cancer patients from TCGA (mutations.csv), and in vitro drug response data from GDSC (drug-sensitivity.csv). </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "89527635-f00d-4d44-96c7-fe85fed311aa",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Our exploratory analysis confirmed strong alignment between clinical HER2 status and measured HER2 pathway signal (pp_HER2). Tumors labeled HER2-positive showed significantly higher pathway activity, especially when stratified by ER/PR receptor status, reinforcing the consistency between clinical annotation and molecular phenotype. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3e434110-6907-4056-8100-93c53a4f3413",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Drug-wise, we found that HER2-targeted agents (like afatinib, lapatinib) achieved lower viability values at lower doses compared to off-target comparators such as PLX-4720. This was reflected in ECDF curves, median response trajectories, and violin plots of viability, all suggesting stronger efficacy of HER2 inhibitors. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5c175576-7fac-4ee2-80b6-bd0e7fb72ce8",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Statistical tests further validated these insights. Directly addressing the first part of our hypothesis, HER2-positive tumors showed substantially higher HER2 pathway activity than HER2-negative tumors (Mann-Whitney U p = $4.81 \\times 10^{-24}$). On the tumor side, high pp_HER2 was also associated with better survival (p = 0.031, OR = 0.54), likely reflecting treatment response rather than tumor aggressiveness. On the drug side, viability distributions between targeted and non-targeted groups were significantly different (Mann-Whitney U p = $1.90 \\times 10^{-209}$), confirming that HER2 inhibitors produce stronger functional effects in vitro. </p> "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5ca18f65-a22b-4e31-9edd-d2884704fadc",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Together, these findings support the idea that HER2 signaling is both a biological marker and a predictive indicator for treatment efficacy. Even though the datasets are independent, their agreement strengthens the translational relevance of HER2 pathway activity - from molecular signal to clinical outcome and pharmacologic sensitivity. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ce6771e4-62c0-4cee-95ff-e07ded120975",
   "metadata": {},
   "source": [
    "## 7. Limitations & Next Steps"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f5947469-6f44-4e9e-b83f-7ee7c9eb2f3c",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> We begin with the question of dataset independence - the mutation dataset (mutations.csv) and the drug sensitivity dataset (drug-sensitivity.csv) originate from different studies and cohorts. As a result, patient‐level linkage is not possible, and cross‐analysis relies on comparing trends across independent datasets rather than matched samples. To add, HER2‐positive cases are underrepresented compared to HER2‐negative cases. This may limit statistical power and potentially bias effect size estimates. Also, the current analysis focuses primarily on HER2 phosphorylation (pp_HER2 or pp_HER2.pY1248). Other relevant signaling markers (like downstream kinases, alternative HER family members) were excluded to streamline the pipeline but could provide a more complete picture. Only a subset of drugs with the highest measurement counts were included for detailed analysis. Rarely tested compounds may still hold biological relevance but could not be robustly assessed. The drug sensitivity metric (viability fraction) measures in vitro cell survival at given doses, which may not fully capture clinical response complexity. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7b270ac8-fa4b-4913-9a42-209563a64ff9",
   "metadata": {},
   "source": [
    "<p style=\"font-size:18px;\"> Next steps may include: leveraging datasets where molecular profiling and drug sensitivity are measured on the same cell lines or patient‐derived organoids. We may include related receptor tyrosine kinases (like EGFR, HER3) and downstream signaling nodes (AKT, MAPK) to assess pathway cross‐talk. It is possible to fit sigmoidal or logistic dose-response models to estimate IC50 values for targeted vs comparator drugs, enabling a more quantitative potency comparison. With access to progression‐free survival and treatment history, we can explore whether HER2 pathway activity predicts clinical outcomes under HER2‐targeted therapy. Additional exploratory analysis of other proteomic features (pp_* variables) could uncover related pathway activity differences beyond HER2. </p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "26011b44-615b-4747-aadf-c51cbe2c765b",
   "metadata": {},
   "source": [
    "## References"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0f3f6146-93ad-4820-8e50-02c73cbdc778",
   "metadata": {},
   "source": [
    "1. Viability dataset - https://depmap.org/portal/data_page/?tab=allData&releasename=Sanger+GDSC1+and+GDSC2&filename=sanger-viability.csv\n",
    "\n",
    "2. Mutation dataset - https://www.kaggle.com/datasets/samdemharter/brca-multiomics-tcga\n",
    "\n",
    "3. Phosphorylation - https://sciencenotes.org/phosphorylation-oxidative-protein-and-glucose\n",
    "\n",
    "4. HER2 - https://www.puls.bg/aktualno-c-6/pri-koi-vidove-rak-e-vazhno-izsledvaneto-za-her2-tumoren-marker-n-50821\n",
    "\n",
    "5. HER2+ BC - https://www.mayoclinic.org/diseases-conditions/breast-cancer/expert-answers/breast-cancer/faq-20058066\n",
    "\n",
    "6. Breast Cancer - https://my.clevelandclinic.org/health/diseases/3986-breast-cancer\n",
    "\n",
    "7. Hypergeometric Distribution - https://www.britannica.com/topic/hypergeometric-distribution\n",
    "\n",
    "8. Mann-Whitney Test - https://datatab.net/tutorial/mann-whitney-u-test\n",
    "\n",
    "9. Cancer drugs - https://www.nejm.org/doi/full/10.1056/NEJMoa1914609\n",
    "\n",
    "10. Fisher's Test - https://statisticsbyjim.com/hypothesis-testing/fishers-exact-test/"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
